{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":774,"total_is_capped":false,"direct_labels_cover":2,"predictions_cover":774,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"query_hash":"8352a2c221bc","filters":{"venue":"Alimentary Pharmacology & Therapeutics"}},"results":[{"id":"W2896437365","doi":"10.1111/apt.15001","title":"Systematic review with meta‐analysis: the efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome","year":2018,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":598,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; Hamilton Health Sciences","funders":"American College of Gastroenterology; Health Research","keywords":"Synbiotics; Medicine; Irritable bowel syndrome; Rifaximin; Internal medicine; Placebo; Randomized controlled trial; Meta-analysis; Adverse effect; Gastroenterology; Antibiotics; Probiotic; Alternative medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.0647723968429816,"gpt":0.361768939476695,"spread":0.2969965426337134,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001304392,0.000880247,0.006912836,0.0004310774,0.0001103534,0.00002560186,0.0005452237,0.0002909797,0.0001111935],"category_scores_gemma":[0.0000085262,0.0005012325,0.001281231,0.001288755,0.001066281,0.00007482364,0.0001919977,0.0008631335,0.00001633533],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001136836,"about_ca_system_score_gemma":0.0003352598,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004054939,"about_ca_topic_score_gemma":0.00005284186,"domain_scores_codex":[0.9951229,0.001148824,0.001920495,0.0007502274,0.000432516,0.0006250365],"domain_scores_gemma":[0.9963073,0.001206093,0.00117367,0.0009240786,0.0002157118,0.0001731486],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.00008878268,0.0008588755,0.0001312125,0.532729,0.4659135,0.00009796159,0.00007045172,0.000006547294,0.000001715557,0.000009721115,0.00004480311,0.00004739851],"study_design_scores_gemma":[0.0008455123,0.001485001,0.00004094706,0.09311055,0.9019019,0.0009444056,0.00007783737,0.0000508075,0.00001619104,0.000005697457,0.001190037,0.0003311378],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001897137,0.9912133,0.00002170399,0.0009094533,0.0001317233,0.007363133,0.0001040016,0.00003907035,0.00002795278],"genre_scores_gemma":[0.001649401,0.9926921,0.001022649,0.004216169,0.00003306929,0.00002533066,0.0001751965,0.00008544396,0.0001007152],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.4396184,"threshold_uncertainty_score":0.9997439,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1483462250","doi":"10.1111/j.1365-2036.2007.03399.x","title":"Systematic review and meta‐analysis: the incidence and prognosis of post‐infectious irritable bowel syndrome","year":2007,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":466,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University","funders":"","keywords":"Irritable bowel syndrome; Medicine; Internal medicine; Odds ratio; Gastroenterology; Incidence (geometry); Meta-analysis; Epidemiology; Anxiety; Psychiatry","retraction":null,"screen_n_in":null,"score":{"opus":0.06787871587370563,"gpt":0.3819148304720897,"spread":0.3140361145983841,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001221714,0.0005152207,0.00491397,0.000270398,0.0001230336,0.000014643,0.0002262469,0.0001597237,0.0002187408],"category_scores_gemma":[0.000003868404,0.0003054711,0.0009757656,0.0006737367,0.0004329164,0.00007390642,0.0001368103,0.0005380937,0.000007291134],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004937299,"about_ca_system_score_gemma":0.0001191428,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001103712,"about_ca_topic_score_gemma":0.0000253144,"domain_scores_codex":[0.9970795,0.0007167588,0.001133957,0.000455332,0.0002615307,0.0003529132],"domain_scores_gemma":[0.9977509,0.000895055,0.0006956957,0.0003640597,0.0001570565,0.0001371905],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.00001600423,0.0002078214,0.00009151678,0.5131342,0.48608,0.00005076963,0.00004339269,2.096984e-7,0.000003200206,0.000004252209,0.000015659,0.0003529304],"study_design_scores_gemma":[0.0002736957,0.0006397043,0.00004306973,0.01635545,0.9779527,0.002702447,0.00006077377,0.000005359589,0.000003555082,0.00001034957,0.001773938,0.0001790038],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001819153,0.9934009,0.00001002016,0.001413165,0.00005277672,0.004822299,0.00005621315,0.00003275439,0.00003000864],"genre_scores_gemma":[0.001063528,0.9818848,0.0001313602,0.01633858,0.00001091827,0.0004054341,0.00005415161,0.00003448148,0.00007671442],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.4967788,"threshold_uncertainty_score":0.9999397,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2017092019","doi":"10.1111/apt.12938","title":"Review article: the economic impact of the irritable bowel syndrome","year":2014,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":453,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"Medical Research Council; University of Nottingham; Nottingham University Hospitals NHS Trust","keywords":"Irritable bowel syndrome; Medicine; Absenteeism; Quality of life (healthcare); Presenteeism; Psychological intervention; Indirect costs; Life expectancy; Health care; Intensive care medicine; Environmental health; Internal medicine; Psychiatry; Population; Nursing","retraction":null,"screen_n_in":null,"score":{"opus":0.05150077381482156,"gpt":0.398853611047545,"spread":0.3473528372327234,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005928599,0.0004474863,0.001599431,0.00005282348,0.0001295636,0.000008544749,0.0005978583,0.0001368173,0.001388805],"category_scores_gemma":[0.000001356807,0.0002245757,0.001284765,0.0001866105,0.0004373033,0.00004553173,0.0001658523,0.000731956,0.000169671],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005068963,"about_ca_system_score_gemma":0.0008205305,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001450137,"about_ca_topic_score_gemma":0.000007742401,"domain_scores_codex":[0.9975973,0.0006662715,0.0008243401,0.0003347222,0.0001454025,0.000431907],"domain_scores_gemma":[0.9982225,0.0004121466,0.0005390237,0.0006751585,0.00004213776,0.0001090432],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0007562235,0.002524475,0.005740385,0.2015789,0.1612496,0.0001415955,0.0002879802,0.0002057724,0.0003785679,0.000114291,0.1119491,0.5150731],"study_design_scores_gemma":[0.0009795107,0.0009862008,0.0004966237,0.01598403,0.1067089,0.002259055,0.00001374067,0.00008401809,0.00001770337,0.00005854202,0.8721597,0.0002520451],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001631853,0.9931173,0.000001646622,0.002275632,0.0005256779,0.002163573,0.0000720327,0.00002448347,0.0001877801],"genre_scores_gemma":[0.001212748,0.9795956,0.00002746989,0.01872598,0.0001001029,0.00009282611,0.00004865329,0.00005157982,0.0001450376],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.7602106,"threshold_uncertainty_score":0.9995241,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1840927757","doi":"10.1111/j.1365-2036.2007.03556.x","title":"Development of a capsule endoscopy scoring index for small bowel mucosal inflammatory change","year":2007,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastrointestinal Bleeding Diagnosis and Treatment","field":"Medicine","cited_by":439,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Capsule endoscopy; Medicine; Endoscopy; Gastroenterology; Internal medicine; Capsule; Inflammatory Bowel Diseases; Stenosis; Inflammatory bowel disease","retraction":null,"screen_n_in":null,"score":{"opus":0.0968124947504707,"gpt":0.3569835534092948,"spread":0.2601710586588241,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003909487,0.0002409072,0.0003176413,0.0001669773,0.0001121116,0.000004839502,0.000111675,0.00007663207,0.00007951535],"category_scores_gemma":[4.193224e-7,0.0002228711,0.0001071412,0.00009582706,0.00009451645,0.00005207054,0.00005993727,0.0001555783,0.000009395004],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002257918,"about_ca_system_score_gemma":0.0001308451,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003142489,"about_ca_topic_score_gemma":0.00003359074,"domain_scores_codex":[0.9985552,0.00002063717,0.0004840335,0.0002748407,0.0001713698,0.0004938856],"domain_scores_gemma":[0.9992822,0.0001353842,0.0001814533,0.000131232,0.0001089408,0.0001608031],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001265408,0.001477297,0.352535,0.0001974511,0.005982896,0.00009690569,0.00185088,0.000003323656,0.6280711,0.00003825121,0.0000904421,0.008391006],"study_design_scores_gemma":[0.006695289,0.001023351,0.1338733,0.0001297028,0.004249923,0.00006174502,0.000376757,0.0001263591,0.8487944,0.00001681691,0.004463071,0.000189291],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9957914,0.0008313953,0.0005932515,0.0008187711,0.0005895102,0.001231938,0.00001205171,0.00005480183,0.00007682644],"genre_scores_gemma":[0.9584568,0.0001199856,0.03524441,0.005447449,0.0003339492,0.0002632755,0.00005476185,0.00004247525,0.00003687054],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2207233,"threshold_uncertainty_score":0.908842,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1709638636","doi":"10.1111/apt.13286","title":"Randomised clinical trial: gut microbiome biomarkers are associated with clinical response to a low <scp>FODMAP</scp> diet in children with the irritable bowel syndrome","year":2015,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":431,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of Nursing Research; National Research Council Canada; National Institutes of Health; North American Society for Pediatric Gastroenterology, Hepatology and Nutrition; NASPGHAN Foundation; Mead Johnson Nutrition; U.S. Department of Agriculture","keywords":"Irritable bowel syndrome; Medicine; Gastroenterology; Internal medicine; Faecalibacterium prausnitzii; Abdominal pain; Crossover study; Microbiome; Gut flora; Placebo; Bioinformatics; Biology; Immunology; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.06440659171302482,"gpt":0.36481654650805,"spread":0.3004099547950252,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.005568622,0.0004563066,0.001045857,0.0002116693,0.0001393093,0.00003462702,0.0004275277,0.0002590823,0.00004389364],"category_scores_gemma":[0.00009141838,0.0003011409,0.0002493441,0.0006824146,0.000856049,0.0001116584,0.0001273096,0.000918968,0.00005001441],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002171081,"about_ca_system_score_gemma":0.0005665431,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008871221,"about_ca_topic_score_gemma":0.0001342121,"domain_scores_codex":[0.9940255,0.002949328,0.001063148,0.0007380638,0.0004037223,0.0008202741],"domain_scores_gemma":[0.9951856,0.00314847,0.0004367498,0.0004617576,0.0002006046,0.0005668687],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.5029823,0.00396644,0.4734882,0.00000826461,0.01095773,0.0002956709,0.0003063663,0.00004261508,0.001566092,2.282539e-7,0.006326305,0.00005982662],"study_design_scores_gemma":[0.3762491,0.0236954,0.5898816,0.0001451891,0.006874598,0.0003632913,0.001132823,0.0001007824,0.000183907,0.00001074373,0.001186018,0.000176498],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9773259,0.0003591926,0.00002646184,0.0172592,0.0004223771,0.004392493,0.00006787955,0.0001046682,0.00004179666],"genre_scores_gemma":[0.9593113,0.00006106425,0.0005130123,0.03936059,0.0001085772,0.00018521,0.0001223327,0.00007166372,0.0002662303],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1267331,"threshold_uncertainty_score":0.9999441,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1486067581","doi":"10.1111/j.1365-2036.2011.04590.x","title":"Review article: the design of clinical trials in hepatic encephalopathy - an International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) consensus statement","year":2011,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":349,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal","funders":"National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"Hepatic encephalopathy; Medicine; Cirrhosis; Encephalopathy; Intensive care medicine; Hyperammonemia; Clinical trial; Rifaximin; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.3161130313169462,"gpt":0.503374709272029,"spread":0.1872616779550828,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.008101855,0.000413988,0.002672109,0.00009354603,0.00007131424,0.00001180281,0.0003027016,0.0001950664,0.0001772759],"category_scores_gemma":[0.000006820504,0.0002719788,0.0008936078,0.0001678614,0.0003327424,0.0001177463,0.00004574686,0.0003952572,0.000005648154],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007589246,"about_ca_system_score_gemma":0.0006627923,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004331376,"about_ca_topic_score_gemma":0.000003059133,"domain_scores_codex":[0.9924111,0.003647131,0.002896777,0.0004948584,0.0002360943,0.0003140404],"domain_scores_gemma":[0.9947323,0.003405171,0.001255936,0.0002900078,0.0001549733,0.000161625],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.004073828,0.0048371,0.00714298,0.05979627,0.1801042,0.0001382643,0.00498715,0.00000457663,0.0005189599,0.0001527954,0.001066917,0.737177],"study_design_scores_gemma":[0.01286659,0.001773327,0.0006023055,0.0150399,0.7452322,0.0001581406,0.0003418732,0.001300876,0.000558163,0.0009175471,0.220414,0.0007951123],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.007827383,0.9836228,0.0001855763,0.0003954043,0.0008211854,0.006701509,0.0004201485,0.00001920605,0.00000674986],"genre_scores_gemma":[0.001016054,0.9847888,0.001714331,0.01080993,0.0002698704,0.000836618,0.0005159784,0.00004215734,0.000006205409],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.7363819,"threshold_uncertainty_score":0.9999732,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2012964005","doi":"10.1111/j.1365-2036.2004.02284.x","title":"Intestinal permeability in patients with irritable bowel syndrome after a waterborne outbreak of acute gastroenteritis in Walkerton, Ontario","year":2004,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":294,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"University of Calgary; Western University; McMaster University","funders":"Canadian Institutes of Health Research; Ontario Ministry of Health and Long-Term Care","keywords":"Irritable bowel syndrome; Medicine; Intestinal permeability; Lactulose; Gastroenterology; Internal medicine; Diarrhea; Etiology; Constipation; Abdominal pain; Small intestinal bacterial overgrowth","retraction":null,"screen_n_in":null,"score":{"opus":0.008196133706756509,"gpt":0.2423013854358155,"spread":0.234105251729059,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001641907,0.0002914066,0.0004920831,0.0001841522,0.00002807108,0.000006542903,0.0001451307,0.00007134311,0.000484839],"category_scores_gemma":[4.051228e-7,0.0002573431,0.00008255687,0.0001930676,0.0003276761,0.0001701842,0.00008353487,0.000471384,0.000009152187],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006556003,"about_ca_system_score_gemma":0.0002002685,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.009710084,"about_ca_topic_score_gemma":0.01425914,"domain_scores_codex":[0.9981264,0.00009308707,0.0005455242,0.0004223582,0.0002418696,0.0005707167],"domain_scores_gemma":[0.9994218,0.00002943288,0.00009856736,0.0002198947,0.00009802021,0.000132267],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01088473,0.00426471,0.9794031,0.00007289074,0.0009632964,0.0005282275,0.001134776,0.00008437967,0.00258647,9.898018e-7,0.000003403979,0.00007304564],"study_design_scores_gemma":[0.01553581,0.005693351,0.974029,0.0002631998,0.001821518,0.0002988589,0.0001309979,0.0000182817,0.001926104,0.0001159769,0.00001604069,0.0001508607],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9969804,0.00005794223,0.00002134642,0.001858258,0.0001151129,0.0008564602,0.00003849837,0.00002252129,0.00004951534],"genre_scores_gemma":[0.9935489,0.00001257719,0.002123115,0.004072661,0.000008248783,0.00007128077,0.00009849448,0.00002654253,0.00003821171],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005374073,"threshold_uncertainty_score":0.9999879,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2598864494","doi":"10.1111/apt.14030","title":"Systematic review with meta‐analysis: comparative efficacy of biologics for induction and maintenance of mucosal healing in Crohn's disease and ulcerative colitis controlled trials","year":2017,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":293,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Alberta Bone and Joint Health Institute; University of Calgary","funders":"UCB Pharma; National Institute of Diabetes and Digestive and Kidney Diseases; National Institutes of Health; Canadian Institutes of Health Research; AbbVie; Merck; Amgen","keywords":"Medicine; Infliximab; Ulcerative colitis; Internal medicine; Maintenance therapy; Azathioprine; Placebo; Gastroenterology; Crohn's disease; Randomized controlled trial; Adalimumab; Odds ratio; Vedolizumab; Meta-analysis; Clinical endpoint; Surgery; Disease; Pathology; Chemotherapy","retraction":null,"screen_n_in":null,"score":{"opus":0.1687696560117198,"gpt":0.440513190622076,"spread":0.2717435346103562,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002240544,0.0004919296,0.00772871,0.0001694984,0.00008740879,0.00001382608,0.0002284687,0.0001877534,0.00001047679],"category_scores_gemma":[0.00002520588,0.0003096939,0.001171565,0.0001077036,0.0004609586,0.00001055648,0.00007742857,0.0001471595,1.621061e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003208636,"about_ca_system_score_gemma":0.0002917878,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000008691009,"about_ca_topic_score_gemma":0.00003259753,"domain_scores_codex":[0.9943538,0.003089658,0.001696104,0.0005055175,0.0001150114,0.0002398859],"domain_scores_gemma":[0.9956646,0.0007944457,0.002858992,0.0003630597,0.0002125232,0.0001063666],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.006029934,0.0002814849,0.00002506704,0.2521665,0.740735,0.00004029142,0.00007952068,0.00002009863,0.000117595,0.00003954606,0.00002286131,0.0004420725],"study_design_scores_gemma":[0.00486298,0.0003052641,0.0002122423,0.01281903,0.98051,0.000008050985,0.00004671595,0.00004122704,0.0000895401,0.00001311249,0.0007744342,0.0003173746],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.003440343,0.9856119,0.00005790522,0.00006875928,0.00007326974,0.009845449,0.0008947346,0.00000407515,0.000003602334],"genre_scores_gemma":[0.007444316,0.9893015,0.0001448958,0.0005971844,0.00005136179,0.001899371,0.0005171736,0.00002451542,0.00001967907],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.239775,"threshold_uncertainty_score":0.9999355,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1540991136","doi":"10.1111/j.1365-2036.2007.03413.x","title":"The safety, tolerance, pharmacokinetic and pharmacodynamic effects of single doses of AT‐1001 in coeliac disease subjects: a proof of concept study","year":2007,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Celiac Disease Research and Management","field":"Medicine","cited_by":282,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Tolerability; Placebo; Gastroenterology; Internal medicine; Intestinal permeability; Coeliac disease; Adverse effect; Gluten; Inflammatory bowel disease; Lactulose; Immunology; Pharmacology; Disease; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.0154350204340273,"gpt":0.3338607176033578,"spread":0.3184256971693306,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006124109,0.0002449552,0.0005076756,0.0002206952,0.00008163026,0.000003804728,0.0002113605,0.00003787649,0.00009918905],"category_scores_gemma":[0.000002539546,0.0001914557,0.0001099351,0.000387955,0.0006697269,0.0000610999,0.0002334675,0.0001894733,7.799705e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001507413,"about_ca_system_score_gemma":0.0001113863,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007605682,"about_ca_topic_score_gemma":0.0000474987,"domain_scores_codex":[0.9976885,0.0003053539,0.0007149833,0.0003127542,0.0004822568,0.0004961853],"domain_scores_gemma":[0.9983506,0.0007625288,0.0002622097,0.0002513424,0.0001256252,0.0002477299],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.02277636,0.009599009,0.08346885,0.001235843,0.007340762,0.0003749235,0.001346373,0.0001377565,0.8417655,0.00001864098,0.000189956,0.03174606],"study_design_scores_gemma":[0.02447011,0.003339344,0.0963669,0.0001781449,0.009890099,0.00000774098,0.0008356724,0.001019081,0.8610632,0.00003769431,0.002563601,0.0002283948],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9753148,0.01993307,0.00003096265,0.0006341732,0.0003125392,0.003518193,0.00004595728,0.00001510817,0.0001952001],"genre_scores_gemma":[0.9944334,0.003963105,0.00002023114,0.001258091,0.00005811155,0.00007624602,0.00002614984,0.00002910989,0.0001355386],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03151767,"threshold_uncertainty_score":0.7807338,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2046404013","doi":"10.1046/j.1365-2036.2003.01646.x","title":"The prevalence of clinically significant endoscopic findings in primary care patients with uninvestigated dyspepsia: the Canadian Adult Dyspepsia Empiric Treatment – Prompt Endoscopy (CADET–PE) study","year":2003,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":277,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Dalhousie University; McMaster University; McGill University; University of Guelph; AstraZeneca (Canada); University of Alberta","funders":"","keywords":"Medicine; Internal medicine; Gastroenterology; Helicobacter pylori; Endoscopy; Reflux; Referral; Peptic; GERD; Peptic ulcer; Disease","retraction":null,"screen_n_in":null,"score":{"opus":0.02436078829560601,"gpt":0.3028056054225864,"spread":0.2784448171269804,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003884966,0.0003787736,0.0004385792,0.0001299656,0.0003950888,0.00002035906,0.0003478602,0.00009744689,0.00008636136],"category_scores_gemma":[0.000007215235,0.0002207907,0.00007985073,0.0004192762,0.0007777486,0.00006832222,0.00003449747,0.000522906,0.000007860563],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007617657,"about_ca_system_score_gemma":0.001353612,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006601918,"about_ca_topic_score_gemma":0.01724398,"domain_scores_codex":[0.9969632,0.000763284,0.0007520629,0.0004976686,0.0003937532,0.0006300553],"domain_scores_gemma":[0.998322,0.0004749834,0.0002334347,0.0004512084,0.0002609821,0.0002573752],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001270291,0.001792127,0.9902187,0.0001108701,0.001676765,0.00004901428,0.003087685,0.00002644736,0.001498496,0.00001385167,0.00002504201,0.0002307074],"study_design_scores_gemma":[0.01270865,0.01314954,0.9603428,0.0001152525,0.005564739,0.00001135358,0.003290151,0.00002586929,0.004259745,0.00002887697,0.0003177267,0.0001852485],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.992424,0.0005250149,0.000001063515,0.002344446,0.0002139751,0.004113278,0.00005542493,0.00002623012,0.0002965947],"genre_scores_gemma":[0.9929489,0.0002365306,0.0003456116,0.006035956,0.00001798155,0.0002187869,0.0000586379,0.00003584783,0.0001017247],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02987586,"threshold_uncertainty_score":0.9980168,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2764071025","doi":"10.1111/apt.14368","title":"Review article: consensus statements on therapeutic drug monitoring of anti‐tumour necrosis factor therapy in inflammatory bowel diseases","year":2017,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":276,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Alberta Bible College","funders":"Gastroenterological Society of Australia; AbbVie; Takeda Pharmaceuticals U.S.A.; Pfizer","keywords":"Medicine; Therapeutic drug monitoring; Infliximab; Adalimumab; Inflammatory bowel disease; Intensive care medicine; Dosing; Drug; Biosimilar; Disease; Internal medicine; Pharmacology","retraction":null,"screen_n_in":null,"score":{"opus":0.07897866906373673,"gpt":0.4131626218953791,"spread":0.3341839528316424,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004008683,0.0009552251,0.00151205,0.0002121189,0.0001929812,0.00004333567,0.001038202,0.0003327519,0.0001362783],"category_scores_gemma":[0.000002465488,0.0008524828,0.000690289,0.0001125517,0.0004078671,0.00002101476,0.0002366456,0.0005128132,0.00004412997],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001596295,"about_ca_system_score_gemma":0.0006126324,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001407373,"about_ca_topic_score_gemma":0.000003447894,"domain_scores_codex":[0.9954658,0.001176262,0.001382943,0.0008806419,0.0003528293,0.0007415576],"domain_scores_gemma":[0.9971699,0.0001330003,0.001273715,0.001062341,0.0001316857,0.0002294113],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002627711,0.004899539,0.1037363,0.05536633,0.05862429,0.001266035,0.0003685431,0.00006011498,0.05320577,0.00001467057,0.004338329,0.7154924],"study_design_scores_gemma":[0.005537295,0.0006676777,0.02466615,0.01897766,0.02033737,0.00002855661,0.00005905089,0.000009466458,0.01624745,0.0000352744,0.9111968,0.002237211],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.1210341,0.8748527,3.421758e-7,0.0001114937,0.001073162,0.002317417,0.0005621457,0.00002869465,0.0000199654],"genre_scores_gemma":[0.01555138,0.9799373,0.00001757883,0.003186218,0.0003421043,0.0004075592,0.0002976918,0.0001670055,0.00009315474],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9068585,"threshold_uncertainty_score":0.9993926,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2089292260","doi":"10.1111/apt.12651","title":"Systematic review with meta‐analysis: the declining risk of colorectal cancer in ulcerative colitis","year":2014,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":263,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Ulcerative colitis; Internal medicine; Incidence (geometry); Meta-analysis; Colorectal cancer; Confidence interval; Gastroenterology; Population; Cumulative incidence; Relative risk; Cancer; Disease; Cohort","retraction":null,"screen_n_in":null,"score":{"opus":0.03330167497267555,"gpt":0.3658335367235048,"spread":0.3325318617508292,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001362738,0.0006082234,0.003616306,0.000140417,0.0001035402,0.00001217233,0.0006461513,0.0002483274,0.000241888],"category_scores_gemma":[0.000002122121,0.000356479,0.001536369,0.000450775,0.0003076054,0.000005596014,0.0001354133,0.0004195083,0.000007773456],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006901623,"about_ca_system_score_gemma":0.0004273625,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005452693,"about_ca_topic_score_gemma":0.0008984614,"domain_scores_codex":[0.9931719,0.004394946,0.001260365,0.0005623976,0.0002361192,0.0003743238],"domain_scores_gemma":[0.9973069,0.000348712,0.001582082,0.0005364873,0.0001433493,0.0000824443],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.0001732275,0.00009662899,0.00008989677,0.1568307,0.8421829,0.00003530999,0.00006360672,0.0001063083,0.00001473571,0.000004467675,0.00005850227,0.0003436603],"study_design_scores_gemma":[0.0004196701,0.0001505066,0.00005156552,0.01117275,0.9773363,0.00001457304,0.00002832453,0.00003513696,0.00009247512,0.000002187533,0.01032677,0.0003697722],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0005143997,0.9950959,0.00001778662,0.00007369417,0.0001428712,0.003578704,0.0005380014,0.000009005593,0.00002961391],"genre_scores_gemma":[0.0007724253,0.9916905,0.00004510698,0.004175856,0.00008308763,0.002831329,0.0002886788,0.00006485029,0.0000481464],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.1456579,"threshold_uncertainty_score":0.9998887,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2012484960","doi":"10.1111/j.1365-2036.2005.02649.x","title":"Prevalence and incidence of gastroduodenal ulcers during treatment with vascular protective doses of aspirin","year":2005,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":263,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"AstraZeneca","keywords":"Medicine; Aspirin; Internal medicine; Incidence (geometry); Odds ratio; Helicobacter pylori; Gastroenterology; Confidence interval; Asymptomatic; Duodenum; Population","retraction":null,"screen_n_in":null,"score":{"opus":0.01146906944599588,"gpt":0.2808042275126172,"spread":0.2693351580666213,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001506225,0.0001825175,0.0003204452,0.00008524473,0.0000499868,0.000001815066,0.0000628617,0.00005206701,0.00009630731],"category_scores_gemma":[2.09053e-7,0.0001357836,0.00005766244,0.00008131765,0.0002931983,0.00008563975,0.0000286201,0.0001157867,0.000002155074],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001395462,"about_ca_system_score_gemma":0.00009668135,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003503685,"about_ca_topic_score_gemma":0.000009201015,"domain_scores_codex":[0.9990066,0.0001110186,0.0002390097,0.0002271162,0.0001955625,0.0002207435],"domain_scores_gemma":[0.9994802,0.00006560332,0.0001528594,0.0001502544,0.00006634521,0.00008470253],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.002045926,0.0004034347,0.1994874,0.0003850557,0.004715497,0.00004007383,0.001425854,0.0001079431,0.7894332,0.000002334009,0.000001956271,0.001951348],"study_design_scores_gemma":[0.004709344,0.003357955,0.09027582,0.0001227873,0.005305005,0.0000893442,0.00009013213,0.0002021401,0.8956043,0.000002846265,0.000133408,0.0001069623],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9965813,0.0020654,0.00001988907,0.0002586764,0.0000593795,0.000966676,0.000009705925,0.00001809443,0.00002086553],"genre_scores_gemma":[0.9971477,0.001272702,0.0008344708,0.0004934678,0.0001273394,0.00007428732,0.000002976392,0.00001814581,0.00002885731],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1092116,"threshold_uncertainty_score":0.5537095,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2625740605","doi":"10.1111/apt.14173","title":"Systematic review with meta‐analysis: faecal microbiota transplantation for the induction of remission for active ulcerative colitis","year":2017,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Clostridium difficile and Clostridium perfringens research","field":"Medicine","cited_by":258,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Western University","funders":"National Health and Medical Research Council","keywords":"Ulcerative colitis; Medicine; Meta-analysis; Fecal bacteriotherapy; Gastroenterology; Internal medicine; Transplantation; Colitis; MEDLINE; Immunology; Antibiotics; Microbiology; Clostridium difficile; Disease","retraction":null,"screen_n_in":null,"score":{"opus":0.2040930666019682,"gpt":0.46352730538288,"spread":0.2594342387809118,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008472992,0.0005406996,0.0045991,0.0002447364,0.0003647807,0.00002245939,0.0004075422,0.0002895278,0.0001481916],"category_scores_gemma":[0.000003179097,0.0002930837,0.002321078,0.0003721174,0.0002601539,0.00007048753,0.00003319365,0.0004760411,0.000002886191],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002531854,"about_ca_system_score_gemma":0.0005664944,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000358357,"about_ca_topic_score_gemma":0.00002275749,"domain_scores_codex":[0.9970934,0.0005901322,0.001057921,0.0005382668,0.0003320084,0.0003882208],"domain_scores_gemma":[0.9959781,0.001640831,0.001221241,0.0005971897,0.0004618139,0.0001008014],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.001200737,0.0001910956,6.495182e-8,0.4231944,0.5679878,0.000006713138,0.0001056288,0.000001172987,0.0003672799,0.000003794511,0.0001696995,0.006771576],"study_design_scores_gemma":[0.001262482,0.0007783276,9.121949e-7,0.03230535,0.910409,0.0001270697,0.0000848103,0.00002887181,0.007599795,0.000001667044,0.04716432,0.0002374223],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00002466807,0.9793317,0.0002571931,0.001435095,0.0001779685,0.01699739,0.001741644,0.00001749318,0.00001684227],"genre_scores_gemma":[0.00008879086,0.9915769,0.0001442774,0.001145606,0.0001731455,0.004650217,0.001763931,0.00006685353,0.0003903192],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.3908891,"threshold_uncertainty_score":0.9999521,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2809196018","doi":"10.1111/apt.14853","title":"An expert consensus to standardise definitions, diagnosis and treatment targets for anti‐fibrotic stricture therapies in Crohn's disease","year":2018,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":258,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Alberta Bible College","funders":"National Institutes of Health; National Institute of Diabetes and Digestive and Kidney Diseases; National Institute for Health and Care Research","keywords":"Medicine; Crohn's disease; Crohn disease; Disease; Consensus conference; Intensive care medicine; MEDLINE; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.06703002966705561,"gpt":0.3776216734310351,"spread":0.3105916437639795,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001646212,0.0007255066,0.0008249295,0.0001964808,0.0002167375,0.00004724633,0.0002953224,0.0003215515,0.0000870931],"category_scores_gemma":[0.000001462274,0.0006264423,0.0003297935,0.0001081933,0.0002688911,0.000008648222,0.00009732509,0.000121697,0.000008806539],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001835696,"about_ca_system_score_gemma":0.0004735502,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001192673,"about_ca_topic_score_gemma":0.00004058019,"domain_scores_codex":[0.9973003,0.0005497254,0.0005388715,0.0009157199,0.0001319024,0.00056352],"domain_scores_gemma":[0.9986632,0.0001247161,0.0001939564,0.0005103343,0.00009124293,0.0004165086],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.01560276,0.01177008,0.01370899,0.01075889,0.08635553,0.005091028,0.003263187,0.0001726002,0.006977352,0.0001389843,0.04127945,0.8048812],"study_design_scores_gemma":[0.002311238,0.00105456,0.001409417,0.0004008947,0.01000233,0.0000132944,0.00009542848,0.00001025509,0.0006042143,0.0000468004,0.9832315,0.0008200802],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.05185784,0.9395404,0.00002354262,0.0002941359,0.0006383268,0.003923505,0.003686523,0.00002963944,0.000006086951],"genre_scores_gemma":[0.002728628,0.985225,0.0007071751,0.005199262,0.0007762374,0.003208682,0.002007655,0.0001287728,0.00001858367],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.941952,"threshold_uncertainty_score":0.9996187,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2552690718","doi":"10.1111/apt.13847","title":"Systematic review with meta‐analysis: comparative efficacy of immunosuppressants and biologics for reducing hospitalisation and surgery in Crohn's disease and ulcerative colitis","year":2016,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":253,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Alberta Bone and Joint Health Institute; University of Calgary","funders":"Canadian Institutes of Health Research; UCB Pharma; National Institutes of Health; Celltrion; Amgen","keywords":"Medicine; Vedolizumab; Infliximab; Ulcerative colitis; Azathioprine; Internal medicine; Adalimumab; Odds ratio; Placebo; Randomized controlled trial; Inflammatory bowel disease; Crohn's disease; Confidence interval; Meta-analysis; Number needed to treat; Surgery; Disease; Relative risk; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.06287299922234953,"gpt":0.3637547067551146,"spread":0.3008817075327651,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005731886,0.0004620484,0.00260302,0.0001608548,0.00007815586,0.00001600591,0.0001261754,0.0001504652,0.00001118021],"category_scores_gemma":[0.000003993116,0.0003043736,0.0004161884,0.0001343934,0.0004059249,0.00001541087,0.0000915635,0.00009592817,3.233572e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002947912,"about_ca_system_score_gemma":0.0001643623,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000005344108,"about_ca_topic_score_gemma":0.000008147174,"domain_scores_codex":[0.9970748,0.001202458,0.0008101531,0.0005721381,0.00009251348,0.0002478678],"domain_scores_gemma":[0.9981589,0.0005955102,0.0007541499,0.0002755524,0.0001041598,0.0001117643],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.00129589,0.0002615289,0.0002826545,0.3546104,0.641872,0.00008660394,0.0002071673,0.000005054317,0.00013106,0.00001812186,0.00007723417,0.001152267],"study_design_scores_gemma":[0.001006683,0.0001823333,0.00237175,0.02355888,0.971021,0.00001624649,0.00005094809,0.00001358354,0.000134223,0.00001428703,0.001079582,0.0005504648],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.02362239,0.9714764,0.00001677668,0.00006687349,0.0000451936,0.004109588,0.0006535131,0.000007708752,0.000001532401],"genre_scores_gemma":[0.009995572,0.9874634,0.00005918243,0.0007543564,0.00003236301,0.001099694,0.0005486527,0.00003525085,0.00001150236],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.3310516,"threshold_uncertainty_score":0.9999408,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2046521127","doi":"10.1111/j.1365-2036.2012.05088.x","title":"Meta‐analysis: vasoactive medications for the management of acute variceal bleeds","year":2012,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":239,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Western University","funders":"","keywords":"Terlipressin; Medicine; Vasoactive; Octreotide; Vasopressin; Vasoactive intestinal peptide; Meta-analysis; Somatostatin; Internal medicine; Placebo; Randomized controlled trial; Relative risk; Confidence interval; Neuropeptide","retraction":null,"screen_n_in":null,"score":{"opus":0.1971172257017816,"gpt":0.439740078915428,"spread":0.2426228532136464,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003213919,0.0003518818,0.001538346,0.0002305193,0.0001348734,0.000005414063,0.0002940648,0.0001541248,0.0007562924],"category_scores_gemma":[2.359358e-10,0.0002150652,0.001829149,0.0005398632,0.000144954,0.00006809123,0.00004141427,0.0002435824,0.00001977869],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007595211,"about_ca_system_score_gemma":0.000127525,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001673862,"about_ca_topic_score_gemma":0.000001114362,"domain_scores_codex":[0.9983876,0.0001966565,0.00054992,0.0002964309,0.0002674932,0.0003018485],"domain_scores_gemma":[0.9985354,0.0005146877,0.0004059272,0.0003502749,0.00008234481,0.0001113528],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.0001212608,0.0004280451,0.000006711555,0.003714056,0.9906885,0.00001095465,0.0002468798,0.000001818864,0.000006123713,0.0001334021,0.000004806458,0.004637466],"study_design_scores_gemma":[0.0008104025,0.0001044124,0.00003574679,0.00008809564,0.9634774,0.00001692133,0.00007549518,0.0000260347,0.00008126025,0.00001924952,0.03510654,0.0001583991],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000004677042,0.9938446,0.001229175,0.0006765971,0.0003922148,0.002754818,0.0009311364,0.00002681465,0.000140015],"genre_scores_gemma":[0.0003206265,0.9926183,0.0006387383,0.002597238,0.0001810014,0.001405807,0.001959942,0.00004050973,0.0002378449],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.03510173,"threshold_uncertainty_score":0.8770104,"prediction_status":"machine_predicted_unvalidated"},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"meta_analysis","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"high"},{"model":"gpt","categories":[],"domain":null,"study_design":"meta_analysis","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"agree"},{"id":"W2161723853","doi":"10.1111/apt.13001","title":"A retrospective analysis: the development of patient reported outcome measures for the assessment of Crohn's disease activity","year":2014,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":235,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Robarts Clinical Trials; Western University","funders":"UCB Pharma; Genentech; Atlantic Healthcare; Relypsa; Astellas Pharma; ActoGeniX; Shire; Bristol-Myers Squibb; Eli Lilly and Company; Orexigen Therapeutics; Biogen; Celgene; Therakos; Novo Nordisk; Teva Pharmaceutical Industries; Gilead Sciences; Takeda Oncology; Tillotts Pharma; Amgen; Pfizer; Ironwood Pharmaceuticals, Incorporated","keywords":"Medicine; Receiver operating characteristic; Crohn's disease; Internal medicine; Disease; Abdominal pain; Methotrexate; Physical therapy; Gastroenterology","retraction":null,"screen_n_in":null,"score":{"opus":0.03300852250896508,"gpt":0.343035266853021,"spread":0.310026744344056,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000713501,0.0001940376,0.0002486749,0.00005198302,0.0002126868,0.000007240523,0.0003139058,0.00006198343,0.00002756795],"category_scores_gemma":[0.00000325458,0.0001248264,0.0002843737,0.0001354673,0.0002473273,0.000005343909,0.0001274042,0.000102016,3.135307e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005412767,"about_ca_system_score_gemma":0.0002295662,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000006403677,"about_ca_topic_score_gemma":0.00003821271,"domain_scores_codex":[0.9983748,0.0003212829,0.0005096428,0.0003028129,0.0002643207,0.0002271555],"domain_scores_gemma":[0.998618,0.00008814163,0.0005071166,0.0004933335,0.0002222273,0.00007116351],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002577675,0.0008674347,0.607972,0.00005562899,0.06380913,0.000009455883,0.0005598565,0.002221915,0.3191901,0.00008847548,0.0001385292,0.002509822],"study_design_scores_gemma":[0.0008341035,0.0001420956,0.8946171,0.000002587149,0.01713423,5.251099e-7,0.0001031803,0.00168318,0.08319133,0.00003802867,0.002110749,0.0001428589],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9917882,0.0001932876,0.006243261,0.0005088294,0.0002706106,0.0008943958,0.00005608879,0.000008080126,0.00003721027],"genre_scores_gemma":[0.9970364,0.00003550795,0.0006432846,0.001871316,0.00006834231,0.0002506592,0.00005234771,0.00001869009,0.00002343674],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2866451,"threshold_uncertainty_score":0.5090275,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1985424042","doi":"10.1111/apt.12177","title":"Systematic review: gastric cancer incidence in pernicious anaemia","year":2012,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":235,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Cancer; Incidence (geometry); Internal medicine; Gastroenterology; Meta-analysis; Pernicious anaemia; Relative risk; Confidence interval","retraction":null,"screen_n_in":null,"score":{"opus":0.07445918309642094,"gpt":0.4121878819648122,"spread":0.3377286988683913,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006852309,0.0007461527,0.004007638,0.0005146554,0.00006545588,0.00001314342,0.0005255544,0.0002610254,0.001455556],"category_scores_gemma":[8.341408e-7,0.0005756872,0.0006252995,0.0009502233,0.0001067553,0.0001177928,0.0002123116,0.000925431,0.0002229201],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001328217,"about_ca_system_score_gemma":0.0003722681,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001520345,"about_ca_topic_score_gemma":0.00003268322,"domain_scores_codex":[0.996125,0.0005593115,0.001512853,0.0005502354,0.0004425513,0.000810032],"domain_scores_gemma":[0.998121,0.0002743011,0.0007999244,0.0005495023,0.00005909108,0.000196166],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00002903788,0.0002722292,0.0009064414,0.9184223,0.01735252,0.0002245548,0.00008351343,4.865387e-7,0.0000043393,0.000002258991,0.002233806,0.06046851],"study_design_scores_gemma":[0.0009556011,0.0001344184,0.00004743313,0.2440226,0.327317,0.0002470036,0.0000265937,0.000007062202,0.000002607467,0.000001348812,0.4267989,0.000439504],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00003443132,0.9912243,0.000002870543,0.0009271506,0.001474054,0.006107322,0.00003443618,0.00007053518,0.0001248929],"genre_scores_gemma":[0.00003592189,0.9622069,0.00005164213,0.03434219,0.0004503742,0.001553863,0.0001602342,0.00009913607,0.001099733],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.6743997,"threshold_uncertainty_score":0.9996694,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2118992568","doi":"10.1111/j.1365-2036.2010.04328.x","title":"Meta‐analysis: factors affecting placebo response rate in the irritable bowel syndrome","year":2010,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":221,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University","funders":"","keywords":"Placebo; Medicine; Irritable bowel syndrome; Meta-analysis; Randomized controlled trial; Internal medicine; Confidence interval; Abdominal pain; MEDLINE; Alternative medicine; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.1608301727157598,"gpt":0.4040069497496291,"spread":0.2431767770338694,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004184953,0.000812499,0.003211786,0.0007009943,0.0002187447,0.00004284045,0.0006071001,0.0004209278,0.001066795],"category_scores_gemma":[0.000005629963,0.0005172384,0.002172658,0.001212899,0.0002793792,0.0001079397,0.0001135662,0.002440681,0.00006371828],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001512402,"about_ca_system_score_gemma":0.0003303133,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001304614,"about_ca_topic_score_gemma":0.0001233775,"domain_scores_codex":[0.9922169,0.005070747,0.0008937547,0.0007219324,0.0003281387,0.0007685194],"domain_scores_gemma":[0.9933067,0.005429481,0.0004373165,0.0006145934,0.00005099256,0.0001609302],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.002900815,0.001677385,0.0009818204,0.002986419,0.9849454,0.001312126,0.001358212,0.0000356127,0.0002607141,0.000002685067,0.0001178671,0.003420989],"study_design_scores_gemma":[0.001126476,0.0006306364,0.0007577071,0.0001869023,0.8502879,0.0006004493,0.0005970777,0.00001755964,0.00003400958,0.00001087732,0.1454324,0.000317973],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.03226342,0.9629629,0.000008723389,0.001584539,0.0004285033,0.002519164,0.00008247491,0.00007416862,0.00007612106],"genre_scores_gemma":[0.0118179,0.9762126,0.0001870273,0.01060067,0.00007787616,0.0003011094,0.0003723758,0.00009965384,0.0003307377],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.1453145,"threshold_uncertainty_score":0.9998607,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1992118657","doi":"10.1111/j.1365-2036.2009.04037.x","title":"Infliximab and other immunomodulating drugs in patients with inflammatory bowel disease and the risk of serious bacterial infections","year":2009,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":214,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"Procter and Gamble; Pfizer; Amgen","keywords":"Medicine; Infliximab; Ulcerative colitis; Inflammatory bowel disease; Azathioprine; Internal medicine; Clostridium difficile; Thiopurine methyltransferase; Relative risk; Gastroenterology; Crohn's disease; Immunology; Antibiotics; Disease; Confidence interval","retraction":null,"screen_n_in":null,"score":{"opus":0.00349494635319812,"gpt":0.2290890353356503,"spread":0.2255940889824522,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001826161,0.0001804606,0.0001369509,0.00004735719,0.0001156479,0.0000136701,0.00009725271,0.00006454569,0.00001957654],"category_scores_gemma":[8.56468e-7,0.0001360627,0.00004002954,0.00004235968,0.00047847,0.00001421127,0.00006912967,0.0001219977,6.462279e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001654606,"about_ca_system_score_gemma":0.00005435633,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002399912,"about_ca_topic_score_gemma":0.00002029036,"domain_scores_codex":[0.9989628,0.0002845885,0.0002470441,0.0002230941,0.00008769233,0.00019481],"domain_scores_gemma":[0.9995083,0.00003017818,0.0001624537,0.0001879836,0.00004115934,0.00006997902],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.008023702,0.0002837188,0.9700122,0.00001535852,0.001537388,0.000004441894,0.0005001526,0.0002069796,0.01877064,0.0000375317,0.00001029395,0.0005975415],"study_design_scores_gemma":[0.0110998,0.0002995485,0.9841777,0.00001001454,0.001378152,0.000001466826,0.00006320154,0.0002223811,0.002208971,0.000100801,0.0002619274,0.0001760553],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9986077,0.0004238961,0.000003519764,0.0001801043,0.0001062231,0.0005865827,0.00005659359,0.000009013673,0.00002636632],"genre_scores_gemma":[0.9969417,0.0002261745,0.00004058482,0.00263475,0.00006272295,0.0000294302,0.00003875131,0.0000187966,0.000007102681],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01656167,"threshold_uncertainty_score":0.5548476,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2034282428","doi":"10.1111/j.1365-2036.2012.05128.x","title":"Review article: current treatment options and management of functional dyspepsia","year":2012,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":212,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University Medical Centre","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Health Services Research and Development; GlaxoSmithKline; AstraZeneca","keywords":"Medicine; Functional gastrointestinal disorder; Prokinetic agent; Tricyclic antidepressant; Placebo; Therapeutic effect; Irritable bowel syndrome; Tricyclic; Internal medicine; Cisapride; Antidepressant; Intensive care medicine; Pharmacology; Alternative medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.1979400496656011,"gpt":0.4318591734435808,"spread":0.2339191237779797,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001654427,0.0003801409,0.001075802,0.00009515357,0.00006386229,0.000003484675,0.00007766073,0.00007507415,0.0008422114],"category_scores_gemma":[7.55122e-8,0.0002943824,0.0003151546,0.0001785457,0.0001910733,0.00004585362,0.00007188827,0.0002428346,0.00006235004],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000176024,"about_ca_system_score_gemma":0.00008809711,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000004268024,"about_ca_topic_score_gemma":9.09372e-7,"domain_scores_codex":[0.9984542,0.000187069,0.0005842112,0.0003130093,0.0001511425,0.0003103666],"domain_scores_gemma":[0.999227,0.00008644186,0.0002376819,0.0002380527,0.00004430924,0.0001664409],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00008398181,0.0018746,0.0001967979,0.05604751,0.01420305,0.00001388661,0.00001979786,3.7956e-7,0.0000122422,0.00007412803,0.0005835837,0.92689],"study_design_scores_gemma":[0.0009965826,0.0004700327,0.0001965601,0.01192526,0.1643491,0.000243841,0.00001428769,0.000003699919,0.000005975059,0.00001152875,0.8216445,0.000138573],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00008529137,0.9965063,0.00001939392,0.0007238434,0.0005011552,0.001958946,0.00005440688,0.00002872572,0.0001218879],"genre_scores_gemma":[0.00002866022,0.9964052,0.0004430949,0.002290382,0.0001196635,0.0002526793,0.0003207668,0.00003074608,0.0001088168],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9267514,"threshold_uncertainty_score":0.9999508,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2079175995","doi":"10.1111/j.1365-2036.2004.02248.x","title":"Meta‐analysis: the efficacy, adverse events, and adherence related to first‐line anti‐<scp>Helicobacter pylori</scp> quadruple therapies","year":2004,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Helicobacter pylori-related gastroenterology studies","field":"Medicine","cited_by":202,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Metronidazole; Omeprazole; Helicobacter pylori; Proton-pump inhibitor; Regimen; Internal medicine; Clarithromycin; Adverse effect; Amoxicillin; Gastroenterology; Drug resistance; Tetracycline; Pharmacology; Antibiotics; Microbiology","retraction":null,"screen_n_in":null,"score":{"opus":0.0894182317054488,"gpt":0.3702053803688568,"spread":0.280787148663408,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0008396415,0.001614723,0.005309063,0.000756963,0.0005664426,0.00002556622,0.0008621367,0.0007843697,0.0004265547],"category_scores_gemma":[0.000004407972,0.00103906,0.002244467,0.001825423,0.0007040947,0.000156306,0.0005844912,0.002025089,0.0003481742],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003161846,"about_ca_system_score_gemma":0.0002976143,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001252494,"about_ca_topic_score_gemma":0.00007963,"domain_scores_codex":[0.9936754,0.001139895,0.001815312,0.001488991,0.0005488645,0.00133154],"domain_scores_gemma":[0.9957926,0.001553886,0.0008756081,0.001090264,0.0002419984,0.0004456048],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.0001195151,0.0007951083,0.001433686,0.001065738,0.9871618,0.0001563471,0.00239821,0.00009465757,0.0000527192,0.000007653045,0.0002637491,0.006450813],"study_design_scores_gemma":[0.002108908,0.0008810334,0.000817896,0.0003839832,0.6358076,0.0001746795,0.0001881191,0.000007735653,0.00003439921,0.00001285464,0.3593324,0.0002502954],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0209431,0.9669179,0.00001889781,0.006378904,0.001244144,0.003958445,0.0002696711,0.0002323455,0.00003661188],"genre_scores_gemma":[0.003466261,0.975297,0.0002479682,0.01854427,0.0002542614,0.0007720744,0.0004947696,0.0001984978,0.0007248645],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.3590687,"threshold_uncertainty_score":0.99966,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2007211118","doi":"10.1046/j.1365-2036.2003.t01-1-01736.x","title":"The economic impact of irritable bowel syndrome","year":2003,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":193,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Irritable bowel syndrome; Medicine; Indirect costs; Functional gastrointestinal disorder; Intensive care medicine; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.06112664255477637,"gpt":0.4076693564151384,"spread":0.346542713860362,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003602519,0.000488958,0.001413879,0.0001185881,0.0001543668,0.0000135767,0.0003365361,0.0002013348,0.001021371],"category_scores_gemma":[3.615791e-7,0.0003184815,0.000995705,0.0001289076,0.0004014572,0.00005413847,0.00007003093,0.0006106725,0.0001519843],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000872173,"about_ca_system_score_gemma":0.00133089,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000132246,"about_ca_topic_score_gemma":0.000007373229,"domain_scores_codex":[0.9978445,0.0003501586,0.0007688365,0.000360976,0.0001322034,0.0005432983],"domain_scores_gemma":[0.9985215,0.0004639984,0.0004149085,0.0004044382,0.00004041976,0.0001547099],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002620468,0.003379419,0.004750461,0.02369437,0.3347318,0.0009016062,0.0003053469,0.0002679393,0.0003649353,0.0002330609,0.02425373,0.6044968],"study_design_scores_gemma":[0.001631357,0.002473961,0.0001523744,0.001039922,0.0647866,0.002881968,0.00004952567,0.00004736366,0.00001835942,0.00009557035,0.9265103,0.0003127332],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002503159,0.9946057,0.000002230083,0.0002074044,0.0007302283,0.001233625,0.0001117728,0.00002889834,0.0005770322],"genre_scores_gemma":[0.0006155487,0.99717,0.0001037687,0.00128937,0.00006470841,0.00006803707,0.0001220122,0.00006696557,0.0004996173],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9022565,"threshold_uncertainty_score":0.9999267,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2056586250","doi":"10.1111/apt.13139","title":"Randomised clinical trial: deep remission in biologic and immunomodulator naïve patients with Crohn's disease – a <scp>SONIC </scp><i>post hoc</i> analysis","year":2015,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":192,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Gastroenterology; Internal medicine; Azathioprine; Infliximab; Post-hoc analysis; Crohn's disease; Randomized controlled trial; Disease","retraction":null,"screen_n_in":null,"score":{"opus":0.02323095278838993,"gpt":0.314365234483963,"spread":0.2911342816955731,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000732322,0.000377599,0.0004829715,0.0001559115,0.0001047307,0.00002834584,0.0003057506,0.0002435837,0.0000266132],"category_scores_gemma":[0.00001235085,0.0003071624,0.0002382288,0.000246828,0.0003446846,0.0000196132,0.0001946638,0.0002368175,0.000008799297],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006857004,"about_ca_system_score_gemma":0.0002849203,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000116684,"about_ca_topic_score_gemma":0.00003294551,"domain_scores_codex":[0.9969625,0.0009562799,0.0006591381,0.0007240369,0.0002105755,0.0004874648],"domain_scores_gemma":[0.9984282,0.0001443019,0.0003020417,0.0004390795,0.000183135,0.0005032985],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.327108,0.002203189,0.6426846,0.00002250526,0.01454594,0.0003996276,0.0002255648,0.0003296236,0.01077238,0.000002612253,0.0003656106,0.001340382],"study_design_scores_gemma":[0.309048,0.002837005,0.6644577,0.00001233089,0.01591968,0.000002992733,0.0002453782,0.0009322561,0.001843985,0.00004208041,0.004253176,0.0004053934],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9951755,0.002518577,0.00003473886,0.0001481578,0.0004464194,0.001545222,0.0000757721,0.00002753365,0.00002808069],"genre_scores_gemma":[0.9908734,0.0007330961,0.0001976097,0.006947186,0.000183011,0.0001504427,0.0008065653,0.0000432911,0.00006537473],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02177316,"threshold_uncertainty_score":0.9999381,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3082374255","doi":"10.1111/apt.16060","title":"Long‐term safety of vedolizumab for inflammatory bowel disease","year":2020,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":191,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Alberta Bible College","funders":"Takeda Pharmaceutical Company","keywords":"Vedolizumab; Medicine; Ulcerative colitis; Internal medicine; Discontinuation; Gastroenterology; Adverse effect; Inflammatory bowel disease; Crohn's disease; Disease","retraction":null,"screen_n_in":null,"score":{"opus":0.01966195509693977,"gpt":0.292556701332228,"spread":0.2728947462352882,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00011474,0.0002664924,0.0001911811,0.00003403204,0.0001068753,0.000007956352,0.0003753542,0.0001209321,0.0001907987],"category_scores_gemma":[0.000001050918,0.0002861517,0.0002220516,0.00004724333,0.0002322208,0.00001058674,0.0001586198,0.0001067782,0.00001670515],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003027708,"about_ca_system_score_gemma":0.0002284277,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":7.797419e-7,"about_ca_topic_score_gemma":0.000002202005,"domain_scores_codex":[0.9985313,0.0001390857,0.0004080202,0.000415992,0.0001416493,0.0003639804],"domain_scores_gemma":[0.9990855,0.00002959736,0.0001755759,0.0002809723,0.0001029533,0.0003253863],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.01692684,0.0003539804,0.1353184,0.0003471454,0.006243594,0.0001305352,0.0002743341,0.0004577205,0.8364483,0.00007479232,0.002507483,0.0009168964],"study_design_scores_gemma":[0.01267367,0.001058338,0.4054793,0.00002857796,0.009376819,0.000009236667,0.0001016406,0.001346926,0.5344274,0.00009519786,0.03438146,0.001021396],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.994112,0.001381983,0.0006748988,0.001860586,0.0004850811,0.0009851112,0.0003960017,0.00003550532,0.00006878778],"genre_scores_gemma":[0.9724166,0.0005597408,0.0002046354,0.02538342,0.0006400314,0.0001113599,0.0005509867,0.00006281915,0.00007036962],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3020209,"threshold_uncertainty_score":0.9999591,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2115112939","doi":"10.1111/apt.12869","title":"Adalimumab drug and antibody levels as predictors of clinical and laboratory response in patients with Crohn's disease","year":2014,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":188,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Adalimumab; Medicine; Internal medicine; Gastroenterology; Crohn's disease; Disease; Immunology; Logistic regression; Drug-naïve; Drug; Pharmacology","retraction":null,"screen_n_in":null,"score":{"opus":0.009706952557712738,"gpt":0.312507872460043,"spread":0.3028009199023302,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006082444,0.0001952666,0.0002184955,0.00006006787,0.00005418655,0.000007581712,0.0001270934,0.0000974377,0.00002644398],"category_scores_gemma":[0.000003590513,0.000177808,0.00003584172,0.00005651334,0.0005357411,0.0000130723,0.0001177286,0.0001293797,0.000001720091],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000009409789,"about_ca_system_score_gemma":0.0001722041,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000005559598,"about_ca_topic_score_gemma":0.000004921609,"domain_scores_codex":[0.9980399,0.0008284373,0.0003920687,0.0003767383,0.0001382452,0.0002246348],"domain_scores_gemma":[0.9992363,0.00008862342,0.0001532519,0.0002284521,0.00008524428,0.0002081076],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02335535,0.0003901905,0.9521734,0.00002706962,0.0009535874,0.00005106736,0.00009035849,0.00001363692,0.02272516,0.000006393065,0.00007187229,0.0001419542],"study_design_scores_gemma":[0.00639321,0.0006016884,0.9847271,0.00001320113,0.0008877073,7.119545e-7,0.00003098247,0.00005179295,0.005544877,0.00001704708,0.001542262,0.0001893812],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9986212,0.000356247,0.000006254543,0.0002311746,0.0002206816,0.000385356,0.0001575497,0.000009386158,0.00001220965],"genre_scores_gemma":[0.994442,0.000162357,0.00007271528,0.00507828,0.00009125041,0.00001480201,0.00008214523,0.00002855071,0.00002784468],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03255378,"threshold_uncertainty_score":0.7250802,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2593531649","doi":"10.1111/apt.14016","title":"Clinical, endoscopic and radiographic outcomes with ustekinumab in medically‐refractory Crohn's disease: real world experience from a multicentre cohort","year":2017,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":185,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia; University of Alberta; University of Calgary","funders":"Canadian Association of Gastroenterology","keywords":"Medicine; Ustekinumab; Refractory (planetary science); Crohn's disease; Cohort; Crohn disease; Cohort study; Internal medicine; Endoscopy; Disease; Gastroenterology; Infliximab","retraction":null,"screen_n_in":null,"score":{"opus":0.02138611916536306,"gpt":0.3504635506227362,"spread":0.3290774314573731,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002140583,0.0003194584,0.0003332433,0.0000826068,0.0003087348,0.00005170246,0.000542852,0.0001395649,0.00018814],"category_scores_gemma":[0.000002643523,0.000277378,0.0001026307,0.00004467929,0.001076791,0.00002886245,0.000244632,0.0002737284,0.000005493443],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003492003,"about_ca_system_score_gemma":0.0001441767,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003022242,"about_ca_topic_score_gemma":0.001363223,"domain_scores_codex":[0.9979125,0.0003144255,0.0004356957,0.0006901401,0.0002217918,0.0004255066],"domain_scores_gemma":[0.9985178,0.00009639296,0.0002672499,0.0007198649,0.00004346406,0.000355194],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001650466,0.0004212593,0.9880289,0.00001142486,0.002653958,0.00106836,0.0001498421,0.000004175189,0.005253059,0.000002978358,0.0001031726,0.0006523879],"study_design_scores_gemma":[0.005236344,0.0001015809,0.9883243,0.00002398143,0.001743669,0.000001395301,0.00009351075,0.0001115167,0.0008445913,0.00001209435,0.003224537,0.0002824972],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9968379,0.001010273,0.000008687314,0.000652496,0.0006224494,0.0006667344,0.00007658618,0.00002229698,0.0001026213],"genre_scores_gemma":[0.988153,0.004558926,0.0002832513,0.006325144,0.0002380895,0.0001344573,0.0001263679,0.00003945931,0.000141257],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008684807,"threshold_uncertainty_score":0.9999678,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2330470789","doi":"10.1111/apt.13594","title":"Vedolizumab induction therapy for inflammatory bowel disease in clinical practice – a nationwide consecutive German cohort study","year":2016,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":184,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Vedolizumab; Medicine; Internal medicine; Ulcerative colitis; Inflammatory bowel disease; Faecal calprotectin; Calprotectin; Gastroenterology; Cohort; Crohn's disease; Clinical endpoint; Infliximab; Disease; Clinical trial","retraction":null,"screen_n_in":null,"score":{"opus":0.02581335356990763,"gpt":0.379374458718892,"spread":0.3535611051489843,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001105048,0.000303041,0.0002218573,0.0001081234,0.0001454455,0.00001714533,0.0002883658,0.0001812625,0.0000713287],"category_scores_gemma":[0.00001277348,0.0002583035,0.0001565251,0.00006928804,0.0002920695,0.00004503722,0.0001011358,0.0001726269,0.00002395994],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001030187,"about_ca_system_score_gemma":0.0004104874,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001041849,"about_ca_topic_score_gemma":0.00002724782,"domain_scores_codex":[0.9970019,0.0009999336,0.0006840849,0.0006766168,0.0002250774,0.0004123833],"domain_scores_gemma":[0.9985728,0.0002749158,0.0003008216,0.0004013237,0.0002525832,0.0001975171],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.014071,0.002381504,0.901606,0.00001126254,0.005687972,0.0001893917,0.0002689029,0.00002315007,0.0725373,0.00004226079,0.001016599,0.002164664],"study_design_scores_gemma":[0.01111142,0.000817133,0.9536759,0.00001005931,0.00180483,0.000008821258,0.0002215174,0.00005888908,0.008871529,0.000129937,0.02288736,0.0004026406],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9929873,0.0004709502,0.0001171407,0.00185445,0.001197798,0.00318807,0.00008917917,0.00003631235,0.00005881787],"genre_scores_gemma":[0.9837828,0.001257541,0.0001318859,0.01294869,0.0006393953,0.0009279861,0.0001108924,0.00005817367,0.0001426697],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06366578,"threshold_uncertainty_score":0.9999869,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2078554097","doi":"10.1111/j.1365-2036.2005.02387.x","title":"Severe haemorrhage following abdominal paracentesis for ascites in patients with liver disease","year":2005,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":182,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal; Hôpital Saint-Luc","funders":"","keywords":"Medicine; Paracentesis; Ascites; Surgery; Complication; Liver disease; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.01557943542679203,"gpt":0.2846785821251181,"spread":0.2690991466983261,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007418757,0.0001862034,0.0002066878,0.00009719338,0.00008658462,0.000008834136,0.00007540386,0.00004346155,0.0002255983],"category_scores_gemma":[5.620394e-8,0.0001593,0.0001096614,0.00009786449,0.00004772117,0.0002235849,0.00001173746,0.0001079736,0.00002212231],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000108798,"about_ca_system_score_gemma":0.00007353591,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001493363,"about_ca_topic_score_gemma":0.00001480836,"domain_scores_codex":[0.9989887,0.00005728513,0.000196688,0.0002664408,0.0001853615,0.0003055606],"domain_scores_gemma":[0.9995248,0.0001078861,0.00005328702,0.0001104587,0.00004194749,0.0001616063],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01163296,0.001544447,0.9740127,0.000102736,0.007734566,0.0001648725,0.0005282139,0.0001097787,0.001101364,0.00000487432,0.0001064998,0.002956973],"study_design_scores_gemma":[0.02846172,0.0007352595,0.9072068,0.0000940991,0.05244806,0.000007019153,0.00008643942,0.002923882,0.006780658,0.00002121925,0.000880377,0.0003544672],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9955787,0.00108215,0.0000958578,0.001687873,0.0001688536,0.001206308,0.0001174817,0.00003461336,0.00002817573],"genre_scores_gemma":[0.9800523,0.0001918419,0.001546421,0.01735681,0.0001402383,0.0001035019,0.0005014452,0.00002933762,0.00007808084],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06680591,"threshold_uncertainty_score":0.6496065,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2085950678","doi":"10.1111/j.1365-2036.2008.03865.x","title":"Systematic review: impact of non‐adherence to 5‐aminosalicylic acid products on the frequency and cost of ulcerative colitis flares","year":2008,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":180,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Systems, Applications & Products in Data Processing (Canada)","funders":"Genentech; National Institutes of Health; Shire; Procter and Gamble; Crohn's and Colitis Foundation of America","keywords":"Medicine; Ulcerative colitis; MEDLINE; Internal medicine; Randomized controlled trial; Inflammatory bowel disease; Comorbidity; Disease; Intensive care medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.03965498665969515,"gpt":0.3681393377354633,"spread":0.3284843510757682,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003425505,0.0005816927,0.001564443,0.00009546915,0.0000975963,0.000007805585,0.0005949084,0.0002125722,0.00006506978],"category_scores_gemma":[0.000009512142,0.000379247,0.0004364128,0.0002148827,0.0003025557,0.00000675201,0.0001678494,0.0002458727,0.0000186161],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009926315,"about_ca_system_score_gemma":0.0006099935,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002523054,"about_ca_topic_score_gemma":0.000007302743,"domain_scores_codex":[0.9966852,0.00120823,0.001003084,0.0005301344,0.0002245925,0.0003487554],"domain_scores_gemma":[0.99791,0.0001369876,0.0008589095,0.0007181161,0.0002477704,0.0001282684],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0008239937,0.001075751,0.0001234356,0.8161036,0.07407948,0.0002570027,0.0008635708,0.000008199823,0.07937028,0.00004977685,0.01668929,0.01055559],"study_design_scores_gemma":[0.005114914,0.01673381,0.00197467,0.507389,0.2033572,0.001278857,0.0002925092,0.0000229284,0.1724344,0.00004868837,0.08594987,0.005403134],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01157116,0.9800637,0.000002698423,0.0001073165,0.0001945909,0.007362349,0.0006287425,0.000007115761,0.00006226795],"genre_scores_gemma":[0.004370913,0.9907392,0.00003754447,0.003390145,0.0001203591,0.0009884341,0.000243152,0.00005753042,0.00005268016],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.3087146,"threshold_uncertainty_score":0.9998659,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2800354113","doi":"10.1111/apt.14688","title":"Systematic review: safety of mesalazine in ulcerative colitis","year":2018,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":179,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; Population Health Research Institute","funders":"Shire","keywords":"Mesalazine; Medicine; Ulcerative colitis; Adverse effect; Internal medicine; Adverse Event Reporting System; Incidence (geometry); Dosing; Renal function; Gastroenterology; Disease","retraction":null,"screen_n_in":null,"score":{"opus":0.02358014853310412,"gpt":0.3491978774057759,"spread":0.3256177288726718,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008061187,0.0005963415,0.0020925,0.0001362131,0.00005640527,0.000006263299,0.0006234826,0.0003813123,0.0002749322],"category_scores_gemma":[0.000002372282,0.0005217798,0.0005504757,0.0002052474,0.0003111117,0.000006288084,0.0002284538,0.0002751864,0.00007320849],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001436394,"about_ca_system_score_gemma":0.0004486091,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000004785029,"about_ca_topic_score_gemma":0.00003286872,"domain_scores_codex":[0.9952914,0.001899537,0.001605591,0.0005779377,0.0002015236,0.0004240338],"domain_scores_gemma":[0.9981192,0.00009688578,0.000897048,0.0006306418,0.0001482833,0.0001079319],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004469765,0.0004109546,0.000018811,0.9649242,0.02757822,0.0001981241,0.00007407444,0.000001075851,0.0002784324,0.00001965251,0.004250132,0.001799405],"study_design_scores_gemma":[0.001943603,0.0004966515,0.00004429167,0.2415203,0.1014821,0.0001209029,0.00003397473,0.000008135592,0.0007675314,0.00001352876,0.652437,0.001132013],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001072879,0.9945386,0.000005375097,0.00005640135,0.0005442711,0.004097147,0.0004079018,0.00001276272,0.0002302228],"genre_scores_gemma":[0.0000247833,0.9917841,0.00005584842,0.005817236,0.0002524545,0.0006030406,0.001057369,0.00008766284,0.0003175193],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.7234039,"threshold_uncertainty_score":0.9997234,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2030153228","doi":"10.1046/j.1365-2036.2003.01640.x","title":"Randomized, double‐blind, placebo‐controlled trial of prednisolone in post‐infectious irritable bowel syndrome","year":2003,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":178,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University","funders":"University of Nottingham; AstraZeneca","keywords":"Enterochromaffin cell; Irritable bowel syndrome; Medicine; Gastroenterology; Prednisolone; Internal medicine; Lamina propria; Placebo; Abdominal pain; Lymphocyte; Serotonin; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.03062201935260886,"gpt":0.3226835841637025,"spread":0.2920615648110937,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001296878,0.0003240868,0.001373418,0.0002891915,0.00007691269,0.000008954889,0.0001341721,0.0001641363,0.000897906],"category_scores_gemma":[0.00000793418,0.0002853332,0.0003703909,0.0002553372,0.0003862499,0.0001144232,0.00003395004,0.0004493043,0.00002636805],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001102383,"about_ca_system_score_gemma":0.0002518508,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002069138,"about_ca_topic_score_gemma":0.00004817453,"domain_scores_codex":[0.9971467,0.0007861839,0.0009043753,0.0003756516,0.000266097,0.0005209592],"domain_scores_gemma":[0.998529,0.0007018665,0.0002713071,0.0002358203,0.0001205354,0.0001414626],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9771438,0.003554056,0.001779451,0.00005233312,0.006486943,0.0001090862,0.000259277,0.0001556906,0.01028896,0.0001008922,0.00003402461,0.00003552478],"study_design_scores_gemma":[0.9800726,0.003868308,0.0001362206,0.00003232852,0.01004538,0.0004565767,0.0002213563,0.0002685635,0.004275549,0.0003460021,0.000104171,0.0001729065],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9852726,0.001271686,0.00004909738,0.002005375,0.000944617,0.007330962,0.000007444249,0.00005682202,0.003061375],"genre_scores_gemma":[0.9929007,0.0003663744,0.0003772631,0.005310312,0.00004772353,0.0005599276,0.00003193165,0.00003456231,0.0003712333],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007628052,"threshold_uncertainty_score":0.9999599,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1907039258","doi":"10.1111/apt.13408","title":"Development of interim patient-reported outcome measures for the assessment of ulcerative colitis disease activity in clinical trials","year":2015,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":173,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Robarts Clinical Trials; Western University","funders":"UCB Pharma; Takeda Oncology; Tillotts Pharma; Genentech; Biogen; Celgene; National Institute for Health and Care Research; Teva Pharmaceutical Industries; Gilead Sciences; Wyeth Pharmaceuticals; Pfizer; ActoGeniX; Bristol-Myers Squibb","keywords":"Medicine; Ulcerative colitis; Mesalazine; Placebo; Internal medicine; Interim analysis; Clinical trial; Inflammatory bowel disease; Clinical endpoint; Interim; Endoscopy; Colonoscopy; Gastroenterology; Disease; Surgery; Pathology; Alternative medicine; Colorectal cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.2507047214101915,"gpt":0.4853118432067941,"spread":0.2346071217966026,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003366178,0.0001887304,0.0004262932,0.00004677496,0.00005252459,0.000005481876,0.0002267158,0.0001007223,0.00002338641],"category_scores_gemma":[0.00002084786,0.0001454099,0.0002161564,0.00005322489,0.0002378515,0.000008392299,0.0001357242,0.0001247797,4.907554e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007735049,"about_ca_system_score_gemma":0.0008614263,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000008595455,"about_ca_topic_score_gemma":0.00006886807,"domain_scores_codex":[0.9966285,0.001348963,0.001305423,0.000285369,0.0002102799,0.0002214937],"domain_scores_gemma":[0.9983591,0.0002910272,0.0007075215,0.0002659391,0.0002302778,0.0001461223],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.03434663,0.003771054,0.4238443,0.0001269279,0.02199529,0.00005860121,0.001375731,0.0005116723,0.4881409,0.00005832424,0.001054318,0.02471631],"study_design_scores_gemma":[0.009397419,0.0008276449,0.7148768,0.00001995432,0.004349746,0.000002147711,0.0006852825,0.001063871,0.2576979,0.00006112822,0.01068066,0.0003375491],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9956237,0.000192211,0.001335533,0.0004201776,0.0007938815,0.001473903,0.0001280471,0.000005685857,0.00002685713],"genre_scores_gemma":[0.9962401,0.00007894454,0.00134764,0.001838106,0.00009343221,0.0002859361,0.00008014055,0.00001960007,0.0000161418],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2910325,"threshold_uncertainty_score":0.5929643,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1553892107","doi":"10.1111/j.1365-2036.2010.04284.x","title":"Meta‐analysis: proton pump inhibitor use and the risk of community‐acquired pneumonia","year":2010,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":172,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University","funders":"Systematics Association","keywords":"Medicine; Community-acquired pneumonia; Pneumonia; Observational study; Odds ratio; Meta-analysis; Internal medicine; MEDLINE; Subgroup analysis; Relative risk; Intensive care medicine; Confidence interval","retraction":null,"screen_n_in":null,"score":{"opus":0.1516494264316733,"gpt":0.3962914887736182,"spread":0.2446420623419449,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009870082,0.0007088838,0.004163573,0.0003275991,0.0003173523,0.00003034994,0.0003702891,0.000399521,0.0002328671],"category_scores_gemma":[0.00000121003,0.0003798007,0.00216883,0.0004812951,0.0009704696,0.0001027746,0.0002431877,0.001487881,0.00001613201],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006382864,"about_ca_system_score_gemma":0.0001400638,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002025943,"about_ca_topic_score_gemma":0.00001552781,"domain_scores_codex":[0.9948556,0.003138994,0.0009373719,0.0003444576,0.0003197685,0.0004037717],"domain_scores_gemma":[0.9964303,0.001485029,0.0009529988,0.0008438394,0.0001176128,0.0001702185],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.0002714225,0.0008910368,0.001356942,0.001591843,0.9786367,0.00006608811,0.0003543648,7.044758e-7,0.00008044134,0.000004530016,0.000009011579,0.01673693],"study_design_scores_gemma":[0.003258443,0.0004495741,0.0002213232,0.00007412958,0.9145101,0.0000757926,0.00002313442,0.000009377091,0.0005473613,0.00002259328,0.08067359,0.0001345446],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.03034841,0.9638656,0.000002156389,0.0002653512,0.0002842494,0.004806273,0.0003680702,0.00004087892,0.00001905569],"genre_scores_gemma":[0.01778542,0.9773876,0.0001559158,0.002862795,0.0001145796,0.0009936409,0.0004237281,0.00007686436,0.0001994339],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.08066458,"threshold_uncertainty_score":0.9998654,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2055562038","doi":"10.1046/j.1365-2036.2001.01113.x","title":"Effect of oral iron supplementation on oxidative stress and colonic inflammation in rats with induced colitis","year":2001,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":171,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"St Joseph's Health Centre; University of Toronto","funders":"Medical Research Council; Crohn's and Colitis Foundation of Canada; Crohn's and Colitis Foundation","keywords":"Colitis; Oxidative stress; Internal medicine; Dextran; Lipid peroxidation; Ulcerative colitis; Sodium; Chemistry; Inflammation; Medicine; Endocrinology; Antioxidant; Vitamin E; Biochemistry; Gastroenterology","retraction":null,"screen_n_in":null,"score":{"opus":0.01875278418831701,"gpt":0.3405334397906135,"spread":0.3217806556022965,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001990426,0.000155458,0.0002585704,0.0001438732,0.00004008644,0.000004452951,0.00004300992,0.00006458065,0.0002242135],"category_scores_gemma":[2.790469e-7,0.0001271676,0.00001976664,0.000161832,0.0001029506,0.00009997902,0.00001642906,0.0001456607,0.000003421768],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006093473,"about_ca_system_score_gemma":0.00004217525,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001914161,"about_ca_topic_score_gemma":0.0001785211,"domain_scores_codex":[0.9989415,0.0003055237,0.0002162833,0.0001828342,0.0001512439,0.0002025583],"domain_scores_gemma":[0.9995979,0.00013603,0.0001054007,0.00008237809,0.00002912494,0.00004916697],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.02222048,0.0006308443,0.3201414,0.000236691,0.001079249,0.00008314708,0.002505434,0.0001113687,0.6336653,0.00007759813,0.00006934859,0.01917911],"study_design_scores_gemma":[0.01465186,0.006478231,0.09870786,0.00004168607,0.002781968,0.00001318161,0.0004998588,0.0001125256,0.8763336,0.00001358975,0.0002380209,0.000127652],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9970899,0.0001675581,0.000004171217,0.001368067,0.0001151101,0.001068582,0.00001926408,0.00001373794,0.0001535774],"genre_scores_gemma":[0.9966037,0.0007319088,0.00006734883,0.002257942,0.00003622531,0.00006705055,0.0001944755,0.00001542649,0.00002590292],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2426683,"threshold_uncertainty_score":0.5185744,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2276029718","doi":"10.1111/apt.13568","title":"A comparison of the gut microbiome between long‐term users and non‐users of proton pump inhibitors","year":2016,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Clostridium difficile and Clostridium perfringens research","field":"Medicine","cited_by":164,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Manitoba","funders":"Janssen Canada; Canadian Institutes of Health Research; Takeda Canada; AbbVie Canada; Science Foundation Ireland; Mylan; Amgen","keywords":"Bacteroidetes; Firmicutes; Microbiome; Confounding; Gut flora; UniFrac; Medicine; Beta diversity; Alpha diversity; Population; Proton-pump inhibitor; Biology; Internal medicine; Bioinformatics; Immunology; Environmental health; Ecology; Species diversity; Genetics; Bacteria; Biodiversity","retraction":null,"screen_n_in":null,"score":{"opus":0.05505738470253866,"gpt":0.382874474158956,"spread":0.3278170894564174,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002283638,0.0002325024,0.0005337454,0.0001560085,0.00008882006,0.000005565767,0.0002685604,0.0001512449,0.0002015404],"category_scores_gemma":[7.809179e-7,0.0001421134,0.0001542185,0.0002799926,0.0007875942,0.00006034762,0.0002212576,0.0002672439,0.000007989895],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001342403,"about_ca_system_score_gemma":0.0001566951,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005781064,"about_ca_topic_score_gemma":0.000006203919,"domain_scores_codex":[0.9982619,0.0001478643,0.0005638886,0.000302579,0.0003240337,0.0003997075],"domain_scores_gemma":[0.9989612,0.0002142521,0.0002482393,0.0003280152,0.0001151873,0.0001330891],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0003497217,0.0002787022,0.4386696,0.0001084828,0.001896086,0.000003231292,0.000287562,3.27641e-7,0.5568675,4.190321e-7,0.0001353919,0.001402953],"study_design_scores_gemma":[0.003639879,0.0007756811,0.1178006,0.0001382028,0.003131474,0.00001118035,0.000125147,0.000007932758,0.873534,0.000003093541,0.0007088396,0.0001239539],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9920356,0.0005993595,0.000005477138,0.00536659,0.0002486957,0.001590843,0.00009101424,0.00001747331,0.00004497589],"genre_scores_gemma":[0.9981707,0.0005657187,0.00002540401,0.0008327712,0.0001603534,0.00004338979,0.00001660075,0.00003316508,0.0001518826],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.320869,"threshold_uncertainty_score":0.5795218,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2106159140","doi":"10.1111/j.1365-2036.2008.03788.x","title":"Prospective evaluation of the pharmacogenetics of azathioprine in the treatment of inflammatory bowel disease","year":2008,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":164,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Thiopurine methyltransferase; Medicine; Azathioprine; ITPA; Inflammatory bowel disease; Adverse effect; Pharmacogenetics; Internal medicine; Gastroenterology; Mercaptopurine; Metabolite; Genotype; Pharmacology; Prospective cohort study; Disease; Immunology","retraction":null,"screen_n_in":null,"score":{"opus":0.05532934038525691,"gpt":0.3649624275969531,"spread":0.3096330872116962,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004877903,0.0001723368,0.000281108,0.0001084866,0.00005957476,9.908284e-7,0.0002665192,0.00005721031,0.0001817993],"category_scores_gemma":[0.000001686626,0.0001016066,0.0001436852,0.0002946804,0.0006929741,0.0000340373,0.00005106358,0.0001391375,0.000002288637],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005659388,"about_ca_system_score_gemma":0.00105943,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004862486,"about_ca_topic_score_gemma":0.000005792949,"domain_scores_codex":[0.9976872,0.0005457695,0.0004862489,0.0001938009,0.0008612424,0.0002257407],"domain_scores_gemma":[0.9987713,0.0002551791,0.0002366596,0.0003604935,0.0003148587,0.00006158139],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.002869408,0.004389401,0.6784487,0.0001046427,0.005075302,0.00005471813,0.007700259,0.001105428,0.2988442,0.00002628637,0.0001302745,0.001251394],"study_design_scores_gemma":[0.01318381,0.0009741287,0.4782459,0.00002858584,0.009782106,0.00003831358,0.0003218876,0.008200616,0.4886905,0.00008996041,0.000358585,0.00008563071],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9934673,0.00260323,0.000004416936,0.001340879,0.0001912775,0.002203975,0.00003985082,0.000006109256,0.0001429211],"genre_scores_gemma":[0.9950201,0.00327603,0.00006119026,0.001325599,0.00008761199,0.0001521351,0.0000141565,0.0000190376,0.00004415024],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2002028,"threshold_uncertainty_score":0.4143399,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1986727655","doi":"10.1111/j.1365-2036.2008.03905.x","title":"Canadian consensus guidelines on long‐term nonsteroidal anti‐inflammatory drug therapy and the need for gastroprotection: benefits versus risks","year":2008,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":159,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"McMaster University; University of Calgary","funders":"Procter and Gamble; Pfizer; Allergan; American Heart Association","keywords":"Medicine; Proton-pump inhibitor; Naproxen; Nonsteroidal; Internal medicine; Drug; COX-2 inhibitor; Lower risk; Clinical trial; Naproxen Sodium; Risk assessment; Intensive care medicine; Pharmacology; Confidence interval; Alternative medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.1100828186055553,"gpt":0.3488717079892668,"spread":0.2387888893837115,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005074565,0.0003636934,0.0004451022,0.0001734781,0.0006794295,0.00001572868,0.0001475817,0.0001524127,0.0001946882],"category_scores_gemma":[0.000001950775,0.0002595628,0.0001620853,0.0001075056,0.0005724878,0.00003719027,0.00002700975,0.0003819992,0.00002017216],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001365667,"about_ca_system_score_gemma":0.0003689759,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002721014,"about_ca_topic_score_gemma":0.001981088,"domain_scores_codex":[0.9981811,0.0002164651,0.0004300942,0.0003645069,0.0002320427,0.0005757654],"domain_scores_gemma":[0.9986168,0.0004462053,0.0001535036,0.0002749649,0.0001953125,0.0003132351],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.1881733,0.001288119,0.4910107,0.0003927856,0.05128953,0.002484607,0.006944784,0.001062926,0.1131524,0.0005424717,0.04518915,0.09846915],"study_design_scores_gemma":[0.2676785,0.007857461,0.3038036,0.0002811275,0.01676322,0.002837782,0.001053017,0.005855526,0.3160442,0.00006164793,0.07561436,0.002149508],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9736348,0.003555922,0.000005693623,0.01737793,0.002690904,0.002496926,0.00004853578,0.00006908506,0.0001201864],"genre_scores_gemma":[0.9607341,0.003488987,0.0001563985,0.03372199,0.001349663,0.0002684297,0.0000456085,0.00006175874,0.0001731266],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2028918,"threshold_uncertainty_score":0.9999856,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4315620344","doi":"10.1111/apt.17370","title":"Systematic review with meta‐analysis: Time to diagnosis and the impact of delayed diagnosis on clinical outcomes in inflammatory bowel disease","year":2023,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":159,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Institute of Infection and Immunity","funders":"School for Public Health Research; Crohn's and Colitis UK; National Institute for Health and Care Research; International Seafood Sustainability Foundation; Wellcome Trust","keywords":"Medicine; Meta-analysis; Inflammatory bowel disease; Disease; Intensive care medicine; MEDLINE; Inflammatory Bowel Diseases; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.06149204477535343,"gpt":0.4126251333228436,"spread":0.3511330885474901,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00186275,0.0008402849,0.004411047,0.0003175173,0.00007674011,0.00002247724,0.0007315399,0.0002573403,0.0002125608],"category_scores_gemma":[0.00001663041,0.0004531552,0.003515178,0.0004650769,0.000382638,0.000008533156,0.0003042608,0.0003731827,0.0001066169],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008046504,"about_ca_system_score_gemma":0.0003638315,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002746835,"about_ca_topic_score_gemma":0.0000254739,"domain_scores_codex":[0.9935433,0.002965477,0.001931319,0.0007956307,0.0003178866,0.0004463338],"domain_scores_gemma":[0.9961116,0.001430509,0.001005854,0.001026911,0.00009474844,0.0003303426],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.0009028697,0.0005117156,0.006247208,0.08744851,0.9036887,0.0002128495,0.00002312533,0.0001374394,8.146212e-7,0.000003251992,0.0006467648,0.0001767756],"study_design_scores_gemma":[0.001251219,0.0004618777,0.001364239,0.01039708,0.984414,0.00000366032,0.000005443751,0.00001963785,0.000003005769,0.000004872026,0.001546791,0.0005281961],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.006663898,0.9852709,9.590341e-7,0.0003425108,0.00007255215,0.006913403,0.0007074646,0.00002288335,0.000005499111],"genre_scores_gemma":[0.0003960559,0.9832502,0.00001030386,0.007380607,0.00006227454,0.008334582,0.0003544101,0.0001094992,0.0001020927],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.0807253,"threshold_uncertainty_score":0.999792,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2034126900","doi":"10.1111/apt.12313","title":"Meta‐analysis: peri‐operative anti‐ <scp>TNF</scp> α treatment and post‐operative complications in patients with inflammatory bowel disease","year":2013,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":155,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University","funders":"American Gastroenterological Association","keywords":"Medicine; Odds ratio; Internal medicine; Ulcerative colitis; Inflammatory bowel disease; Perioperative; Meta-analysis; Gastroenterology; Confidence interval; Surgery; Disease","retraction":null,"screen_n_in":null,"score":{"opus":0.03577937100372532,"gpt":0.3318719965706866,"spread":0.2960926255669613,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001321872,0.00101761,0.001551495,0.0003284626,0.0002551308,0.00006939135,0.0003929566,0.000301485,0.0001282632],"category_scores_gemma":[7.273334e-7,0.0007472202,0.0007487786,0.000251147,0.0004414653,0.00003509875,0.0002041986,0.0002946377,0.00004571279],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001828778,"about_ca_system_score_gemma":0.0005394546,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001995848,"about_ca_topic_score_gemma":0.00004758709,"domain_scores_codex":[0.9963627,0.001046721,0.0007291276,0.001090875,0.0002040214,0.000566593],"domain_scores_gemma":[0.9981731,0.0001098582,0.0004186608,0.0006600191,0.0002608923,0.0003774358],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.0002104207,0.00218074,0.02709638,0.0008994658,0.9644227,0.0001173708,0.0006572001,0.0002768605,0.000418318,0.00002420437,0.0001732365,0.003523079],"study_design_scores_gemma":[0.002706997,0.0006687116,0.04536017,0.00008814904,0.8165288,0.000004668202,0.0001498628,0.0000496596,0.000168201,0.000003562505,0.1336288,0.0006424901],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.19524,0.7997919,0.000006884365,0.00008973086,0.0001019528,0.003455958,0.001248029,0.00002613787,0.00003933565],"genre_scores_gemma":[0.01023628,0.9762359,0.0001340588,0.003694502,0.000118781,0.0028189,0.006288102,0.0001373909,0.00033609],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.1850037,"threshold_uncertainty_score":0.9994979,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1985110054","doi":"10.1111/j.1365-2036.2005.02648.x","title":"Review article: endocannabinoids and their receptors in the enteric nervous system","year":2005,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":155,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"Canadian Institutes of Health Research; Alberta Heritage Foundation for Medical Research; Canadian Association of Gastroenterology","keywords":"Enteric nervous system; Endocannabinoid system; Cannabinoid receptor; Gastrointestinal tract; Receptor; Cannabinoid; Medicine; Nervous system; Irritable bowel syndrome; Pharmacology; Neuroscience; Biology; Internal medicine; Agonist","retraction":null,"screen_n_in":null,"score":{"opus":0.05934677270054484,"gpt":0.3931298152260362,"spread":0.3337830425254913,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001116495,0.0006715678,0.001931004,0.0002591372,0.0001450456,0.00003752916,0.0005247876,0.0002702071,0.0005635626],"category_scores_gemma":[6.524915e-7,0.0003876005,0.0004767065,0.0007266256,0.0003230323,0.00007078503,0.0001786928,0.00133665,0.00006555804],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005443292,"about_ca_system_score_gemma":0.0003974621,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004962715,"about_ca_topic_score_gemma":0.000009001463,"domain_scores_codex":[0.9959437,0.001356128,0.0009800605,0.0006246403,0.0003246614,0.0007708375],"domain_scores_gemma":[0.9987852,0.0001027423,0.0002742896,0.000562375,0.00007202625,0.0002033695],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00004811326,0.0003122995,0.00001782699,0.02531398,0.00321091,0.0001323929,0.00025974,1.282518e-7,0.00004999516,0.00001091609,0.04349203,0.9271517],"study_design_scores_gemma":[0.0008631475,0.0003649041,0.00001663684,0.01029491,0.01567855,0.001861333,0.0003106759,0.00001688666,0.00002554279,0.000001364433,0.9702597,0.0003063289],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001773454,0.9806423,8.511287e-7,0.01429733,0.0006613596,0.003818176,0.00004834171,0.00005748859,0.0002968678],"genre_scores_gemma":[0.00007179099,0.956079,0.00001327766,0.04104992,0.000651104,0.001044897,0.0001346209,0.00008950937,0.0008658759],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9268453,"threshold_uncertainty_score":0.9998576,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1911381531","doi":"10.1111/apt.13432","title":"Miravirsen dosing in chronic hepatitis C patients results in decreased micro<scp>RNA</scp>‐122 levels without affecting other micro<scp>RNA</scp>s in plasma","year":2015,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":154,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University Health Network","funders":"Cilag; Alnylam Pharmaceuticals; Gilead Sciences; Janssen Research and Development; Innogenetics; Novartis; MedImmune; Roche; AbbVie; Merck; Bristol-Myers Squibb","keywords":"Medicine; Dosing; Placebo; Internal medicine; Gastroenterology; Chronic hepatitis; RNA; microRNA; Immunology; Pharmacology; Virus; Pathology; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.02910347638518196,"gpt":0.3047417585793402,"spread":0.2756382821941583,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007322361,0.0005483193,0.0004818949,0.0003458378,0.00009356837,0.00004446995,0.0004601406,0.0004467997,0.0000216292],"category_scores_gemma":[0.00002171902,0.0006242637,0.0001264223,0.0004110972,0.0002042611,0.00004545275,0.00024526,0.0004200244,0.00004025128],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008976549,"about_ca_system_score_gemma":0.0004415612,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001002947,"about_ca_topic_score_gemma":0.00206616,"domain_scores_codex":[0.9961095,0.0008391332,0.000891758,0.0009234343,0.0002784465,0.0009577336],"domain_scores_gemma":[0.9985586,0.0002240022,0.0004304867,0.0004261779,0.0001241948,0.0002365057],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0002752469,0.0009098048,0.1492023,0.00003434564,0.0006302998,0.00003868559,0.0009774044,0.0007096195,0.8454401,5.559473e-7,0.0009339162,0.0008476926],"study_design_scores_gemma":[0.01832687,0.0005721581,0.05236104,0.0001211029,0.0004559492,0.00001581613,0.0002850319,0.001040344,0.9141015,0.00002835208,0.01245018,0.0002416792],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9946589,0.002820997,0.0000217737,0.000142433,0.0005500041,0.001194845,0.0002173267,0.00003337542,0.0003603408],"genre_scores_gemma":[0.994912,0.0002860322,0.0007723596,0.002588587,0.0002804662,0.00008533207,0.0006568372,0.000118886,0.0002995087],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.09684129,"threshold_uncertainty_score":0.9996209,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2091756720","doi":"10.1046/j.1365-2036.2000.00751.x","title":"Rifaximin versus chlortetracycline in the short‐term treatment of small intestinal bacterial overgrowth","year":2000,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Travel-related health issues","field":"Medicine","cited_by":154,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Rifaximin; Medicine; Tolerability; Gastroenterology; Internal medicine; Malabsorption; Antibiotics; Small intestinal bacterial overgrowth; Lactulose; Chlortetracycline; Breath test; Pharmacology; Microbiology; Adverse effect; Irritable bowel syndrome; Helicobacter pylori; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.09250608591400745,"gpt":0.3831571815284455,"spread":0.290651095614438,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002032674,0.0002977684,0.0004631888,0.0001239589,0.0000722527,0.000006638785,0.0002108178,0.0001568811,0.002993931],"category_scores_gemma":[3.020072e-7,0.000217973,0.0001170386,0.0002244544,0.0002304528,0.00005457279,0.00001536367,0.0003263805,0.00004294678],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002408554,"about_ca_system_score_gemma":0.0001338227,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002951611,"about_ca_topic_score_gemma":0.0001095207,"domain_scores_codex":[0.9981418,0.0002304625,0.0006268232,0.0003193339,0.0002039869,0.0004776409],"domain_scores_gemma":[0.9990957,0.0003759844,0.00009216637,0.0002875431,0.00003465124,0.0001139751],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.104621,0.02084073,0.1937528,0.000227934,0.01934244,0.001997082,0.02178877,0.0001170199,0.4236493,0.0000727613,0.0004370838,0.2131532],"study_design_scores_gemma":[0.06382795,0.03728261,0.5940558,0.0001879342,0.02868528,0.0006455088,0.0009746981,0.001010634,0.2230908,0.0000845126,0.0493099,0.0008443853],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9913785,0.001257582,0.000001856766,0.004627334,0.0008724715,0.000987791,0.00003009172,0.00004384168,0.0008005645],"genre_scores_gemma":[0.9893394,0.004014263,0.0005146989,0.005176809,0.0005396442,0.00006837305,0.0001810816,0.00003644491,0.0001292984],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.400303,"threshold_uncertainty_score":0.9979175,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3017396921","doi":"10.1111/apt.15719","title":"Efficacy and safety of simultaneous treatment with two biologic medications in refractory Crohn’s disease","year":2020,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":149,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary; Western University","funders":"National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"Medicine; Crohn's disease; Infliximab; Adalimumab; Ustekinumab; Internal medicine; Vedolizumab; Refractory (planetary science); Golimumab; Concomitant; Clinical trial; Maintenance therapy; Surgery; Gastroenterology; Cohort; Disease; Chemotherapy","retraction":null,"screen_n_in":null,"score":{"opus":0.01796199513324832,"gpt":0.3002074370836827,"spread":0.2822454419504344,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005338746,0.0001876937,0.0001632488,0.00003269274,0.00005415842,0.000003474162,0.0001339424,0.00006093199,0.00008063792],"category_scores_gemma":[6.742787e-7,0.000153703,0.00003763793,0.00006717941,0.0002867756,0.000004728407,0.00005965883,0.00007781053,0.000004306807],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000378146,"about_ca_system_score_gemma":0.0001467581,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001075905,"about_ca_topic_score_gemma":0.0000196467,"domain_scores_codex":[0.9989832,0.000172557,0.0002343946,0.0003308998,0.00007592247,0.0002030276],"domain_scores_gemma":[0.9994317,0.00006740401,0.00009843528,0.0001688063,0.00003252357,0.000201154],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.02416048,0.001560992,0.09838611,0.00005281087,0.005702659,0.001201654,0.0008183991,0.002437084,0.8603342,0.00002522339,0.00007251371,0.005247923],"study_design_scores_gemma":[0.06921725,0.01053693,0.6293106,0.00007618278,0.01946205,0.00005211341,0.0009315611,0.00750386,0.2013911,0.00008397791,0.05937866,0.002055708],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9959354,0.001833186,0.00003716047,0.001426362,0.00005766761,0.0005436465,0.0001067223,0.00001502666,0.00004476212],"genre_scores_gemma":[0.9894668,0.002217853,0.0001628434,0.007756966,0.0001019383,0.00004635505,0.0002067511,0.00001989454,0.00002054591],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6589431,"threshold_uncertainty_score":0.6267828,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2070335189","doi":"10.1111/j.1365-2036.2008.03722.x","title":"Autoimmune hepatitis overlap syndromes: an evaluation of treatment response, long‐term outcome and survival","year":2008,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":148,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Alberta Innovates - Health Solutions","keywords":"Autoimmune hepatitis; Medicine; Overlap syndrome; Gastroenterology; Internal medicine; Primary biliary cirrhosis; Primary sclerosing cholangitis; Hepatitis; Disease","retraction":null,"screen_n_in":null,"score":{"opus":0.1532804977388328,"gpt":0.4080750898387793,"spread":0.2547945920999465,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004682916,0.0002136367,0.0004066407,0.0001069778,0.0001607769,0.000004862559,0.00009350223,0.00008008671,0.000887847],"category_scores_gemma":[6.243898e-7,0.0001853932,0.0001025091,0.0001049344,0.0002748756,0.0001513918,0.00004725776,0.0001153807,0.000009110308],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003676854,"about_ca_system_score_gemma":0.0002901977,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004522795,"about_ca_topic_score_gemma":0.00001143402,"domain_scores_codex":[0.9980642,0.0007818242,0.0003666774,0.000238505,0.0003148902,0.0002338941],"domain_scores_gemma":[0.9991233,0.0001451028,0.0001314029,0.0003079896,0.000162058,0.0001301416],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002650616,0.001304727,0.9144723,0.00002337081,0.005537082,0.00007098877,0.0009549861,0.000009157697,0.07281048,0.000002807835,0.0000130419,0.002150368],"study_design_scores_gemma":[0.007611081,0.003919397,0.9634656,0.00001389542,0.01508546,0.0002016722,0.000154516,0.000913017,0.008326706,0.000008321142,0.000150363,0.0001500145],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9944634,0.003489072,0.000004291078,0.0006705551,0.000479002,0.0007349105,0.00007173496,0.00003919518,0.00004787725],"genre_scores_gemma":[0.9929268,0.004321014,0.00007036285,0.002169073,0.00005439012,0.00004029612,0.0001775082,0.00002553336,0.0002150551],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06448378,"threshold_uncertainty_score":0.9721302,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2051273236","doi":"10.1111/j.1365-2036.2005.02368.x","title":"A randomized comparative study of esomeprazole 40 mg versus pantoprazole 40 mg for healing erosive oesophagitis: the EXPO study","year":2005,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":148,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Western University; McMaster University Medical Centre","funders":"","keywords":"Esomeprazole; Pantoprazole; Heartburn; Medicine; Gastroenterology; Internal medicine; Randomized controlled trial; Reflux; Omeprazole; Disease","retraction":null,"screen_n_in":null,"score":{"opus":0.1051380690232497,"gpt":0.4188200492843938,"spread":0.313681980261144,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007102424,0.0004794793,0.001330009,0.0001428145,0.0003774966,0.0000214345,0.0003112471,0.00008664125,0.0002299035],"category_scores_gemma":[0.000001640479,0.0003275387,0.000299073,0.000222338,0.0003197632,0.0001468777,0.0001196272,0.0003607383,0.00003019046],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001965297,"about_ca_system_score_gemma":0.0001043632,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008587201,"about_ca_topic_score_gemma":0.00004941025,"domain_scores_codex":[0.9967595,0.000760336,0.0008795077,0.0005397387,0.0004556393,0.0006052568],"domain_scores_gemma":[0.9974679,0.00131653,0.0004188999,0.0004198636,0.0002114482,0.000165358],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6601404,0.04852694,0.03823801,0.00006898501,0.1520937,0.0003967365,0.0750229,0.000833447,0.02107923,0.00003684686,0.0007070663,0.002855769],"study_design_scores_gemma":[0.8520104,0.01446416,0.008840859,0.00002121589,0.0522409,0.00002949808,0.02508125,0.001817831,0.04480929,0.00003756828,0.0003887608,0.0002582101],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9858444,0.002060357,0.00003463851,0.001071217,0.0008428444,0.009895973,0.00006982277,0.00006586468,0.0001148621],"genre_scores_gemma":[0.9931734,0.0001835318,0.0003675713,0.004101731,0.0003697391,0.001500748,0.00008257783,0.00005162602,0.0001690962],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.19187,"threshold_uncertainty_score":0.9999177,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2068567051","doi":"10.1046/j.1365-2036.2004.01819.x","title":"Monitoring methotrexate‐induced hepatic fibrosis in patients with psoriasis: are serial liver biopsies justified?","year":2004,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":141,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Methotrexate; Psoriasis; Cirrhosis; Liver biopsy; Biopsy; Gastroenterology; Cumulative dose; Internal medicine; Fibrosis; Hepatic fibrosis; Dermatology","retraction":null,"screen_n_in":null,"score":{"opus":0.03170977428032595,"gpt":0.2736131386756533,"spread":0.2419033643953274,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000163334,0.0004672944,0.0005151911,0.0002313009,0.0002637069,0.00001927192,0.0003065431,0.0003316628,0.0003219935],"category_scores_gemma":[4.851046e-7,0.0003982809,0.0001083404,0.0003258825,0.0001642333,0.0002230013,0.00009029763,0.0003221012,0.0001870544],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002774016,"about_ca_system_score_gemma":0.00007586893,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004081328,"about_ca_topic_score_gemma":0.00007196339,"domain_scores_codex":[0.9978346,0.000440462,0.0004146728,0.000541988,0.00009067529,0.0006776174],"domain_scores_gemma":[0.9991983,0.0001635594,0.0002326021,0.0002748916,0.00008007063,0.00005053099],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00520731,0.002066696,0.4671095,0.00004123646,0.01360812,0.0000776802,0.002222458,0.0001917594,0.500319,0.00001014057,0.00003369413,0.009112387],"study_design_scores_gemma":[0.0156939,0.0009272452,0.3105814,0.00007924889,0.006568849,0.000008419946,0.0004407426,0.000001566836,0.6648793,0.00002947348,0.0003382023,0.0004516504],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9925366,0.002458185,0.000005966949,0.000328532,0.00375582,0.0006820819,0.00009452121,0.0001096392,0.00002862452],"genre_scores_gemma":[0.997139,0.0007609418,0.000513431,0.0009432177,0.000190977,0.0001397149,0.0001734687,0.00005550341,0.00008377002],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1645603,"threshold_uncertainty_score":0.9998469,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2170684362","doi":"10.1111/apt.13465","title":"Combined ursodeoxycholic acid (<scp>UDCA</scp>) and fenofibrate in primary biliary cholangitis patients with incomplete<scp>UDCA</scp>response may improve outcomes","year":2015,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":138,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Mount Sinai Hospital; Toronto Western Hospital; Public Health Ontario; Centre for Global Health Research; University of Toronto; University Health Network","funders":"Medical Research Council","keywords":"Ursodeoxycholic acid; Fenofibrate; Medicine; Gastroenterology; Internal medicine; Primary (astronomy)","retraction":null,"screen_n_in":null,"score":{"opus":0.02436450036787743,"gpt":0.284808488986843,"spread":0.2604439886189656,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006401489,0.0006381027,0.0008800597,0.0003913045,0.0002118596,0.00006452345,0.0003994541,0.0002395722,0.00004797048],"category_scores_gemma":[0.000009577457,0.0005278693,0.0001427364,0.0004418415,0.00050705,0.0005302634,0.0003977933,0.0007199828,0.00006007818],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004309043,"about_ca_system_score_gemma":0.0003833529,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002342442,"about_ca_topic_score_gemma":0.000007872865,"domain_scores_codex":[0.9963589,0.0008480335,0.0006202626,0.0006853779,0.0005723654,0.0009150403],"domain_scores_gemma":[0.9973959,0.000852295,0.0002875397,0.0005848687,0.0002281469,0.0006512692],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002855444,0.002490947,0.9158609,0.00008556078,0.004611546,0.0001568024,0.002071451,0.000004785818,0.06938391,0.000004308634,0.001497413,0.0009769512],"study_design_scores_gemma":[0.02580593,0.003784747,0.9393473,0.0000488741,0.004254838,0.00002914903,0.0008031537,0.0001135573,0.02070144,0.0000799406,0.004843816,0.0001872842],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9930012,0.001957424,0.000006188304,0.001579367,0.0008204269,0.001770248,0.0003262042,0.0001419291,0.0003970465],"genre_scores_gemma":[0.9556887,0.0005038618,0.0004069972,0.04181609,0.0001145847,0.0001240947,0.0005820451,0.0001139307,0.0006497729],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04868247,"threshold_uncertainty_score":0.9997173,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2034545752","doi":"10.1111/j.1365-2036.2009.03966.x","title":"Evaluation of the meaningfulness of health‐related quality of life improvements as assessed by the SF‐36 and the EQ‐5D VAS in patients with active Crohn’s disease","year":2009,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":135,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Western University","funders":"","keywords":"Minimal clinically important difference; Medicine; Certolizumab pegol; Visual analogue scale; Quality of life (healthcare); Physical therapy; Randomized controlled trial; Clinical trial; EQ-5D; Disease; Severity of illness; Health related quality of life; Internal medicine; Adalimumab","retraction":null,"screen_n_in":null,"score":{"opus":0.03266739989800522,"gpt":0.3220892232477344,"spread":0.2894218233497292,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001827877,0.0001629794,0.0002360987,0.00002359124,0.0001058542,0.000004289862,0.0002842439,0.00006432909,0.00003038383],"category_scores_gemma":[0.0000085193,0.0000923238,0.00007192626,0.0001059988,0.0004600665,0.00001206158,0.00008190662,0.0001263483,2.097254e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005035647,"about_ca_system_score_gemma":0.0004220422,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001352267,"about_ca_topic_score_gemma":0.00001923476,"domain_scores_codex":[0.9962489,0.002341263,0.0005466573,0.0002201248,0.0004586294,0.0001844317],"domain_scores_gemma":[0.9985712,0.0000788307,0.000692282,0.0003211502,0.0002820479,0.00005451676],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.08968063,0.00809379,0.4812483,0.0002864312,0.02270273,0.000004197136,0.006514634,0.002458872,0.3515059,0.0003554951,0.0004929256,0.03665613],"study_design_scores_gemma":[0.01207763,0.0003514342,0.9243844,0.00001518552,0.00205851,1.698405e-7,0.0002614196,0.0002947384,0.06005733,0.0003676711,0.00002069629,0.0001107826],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9958568,0.0009025246,0.000006213353,0.001460214,0.0001150931,0.00152598,0.0001023229,0.000002646905,0.00002824381],"genre_scores_gemma":[0.9938571,0.00006185145,0.000004506627,0.005913499,0.00001075676,0.00005333843,0.00007963548,0.00001185087,0.000007397011],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4431362,"threshold_uncertainty_score":0.3764856,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}